UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☒

~~QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

For the quarterly period ended September 30, ~~2020~~2021

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐

~~TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

Commission File Number 001-37839

TPI Composites, Inc.

(Exact name of registrant as specified in its charter)

Delaware

20-1590775

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

8501 N. Scottsdale Rd.

Gainey Center II, Suite 100

Scottsdale, AZ85253

~~(480)~~ (480) 305-8910

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01	TPIC	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒		Accelerated filer	☐
Non-accelerated filer	☐		Smaller reporting company	☐
~~Non-accelerated filer~~Emerging growth company	☐	☐	~~Smaller reporting company~~	☐
~~Emerging growth company~~	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October ~~31, 2020,~~29, 2021, there were ~~35,740,796~~37,070,744 shares of common stock outstanding.

TPI COMPOSITES, INC. AND SUBSIDIARIES

INDEX


		Page

PART I. FINANCIAL INFORMATION

ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)	4

	Condensed Consolidated Balance Sheets as of September 30, ~~2020~~2021 and December 31, ~~2019~~2020	54

	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, ~~2020~~2021 and ~~2019~~2020	65

	Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, ~~2020~~2021 and ~~2019~~2020	76

	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, ~~2020~~2021 and ~~2019~~2020	87

	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, ~~2020~~2021 and ~~2019~~2020	109

	Notes to Condensed Consolidated Financial Statements (Unaudited)	1211

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2526

ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	3738

ITEM 4.	Controls and Procedures	3839

PART II. OTHER INFORMATION

ITEM 1.	Legal Proceedings	3940

ITEM 1A.	Risk Factors	3940

ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3940

ITEM 3.	Defaults Upon Senior Securities	3940

ITEM 4.	Mine Safety Disclosures	3941

ITEM 5.	Other Information	3941

ITEM 6.	Exhibits	4042

SIGNATURES		4143

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:



the potential impact of the COVID-19 pandemic on our business and results of operations;



competition from other wind blade and wind blade turbine manufacturers;



our ability to procure adequate supplies of raw materials and components in a cost-effective manner to fulfill our volume commitments to our customers;



the discovery of defects in our products and our ability to estimate the future cost of warranty campaigns;



growth of the wind energy and electric vehicle markets and our addressable markets for our products and services;



the potential impact of the increasing prevalence of auction-based tenders in the wind energy market and increased competition from solar energy on our gross margins and overall financial performance;



our future financial performance, including our net sales, cost of goods sold, gross profit or gross margin, operating expenses, ability to generate positive cash flow, and ability to achieve or maintain profitability;



changes in domestic or international government or regulatory policy, including without limitation, changes in trade policy and a potential extension of the Production Tax Credit in the United States;



the sufficiency of our cash and cash equivalents and our ability to raise additional capital to meet our liquidity needs;



our ability to attract and retain customers for our products, and to optimize product pricing;



our ability to effectively manage our growth strategy and future expenses, including our startup and transition costs;



our ability to successfully expand in our existing wind energy markets and into new international wind energy markets, including our ability to expand our field service inspection and repair services business and manufacture wind blades for offshore wind energy projects;



our ability to successfully open new manufacturing facilities, take over existing facilities of our customers and expand our existing facilities on time and on budget;



the impact of the accelerated pace of new product and wind blade model introductions on our business and our results of operations;



our ability to successfully expand our transportation business and execute upon our strategy of entering new markets outside of wind energy;



worldwide economic conditions and their impact on customer demand;



our ability to maintain, protect and enhance our intellectual property;



our ability to comply with existing, modified or new laws and regulations applying to our business, including the imposition of new taxes, duties or similar assessments on our products;



the attraction and retention of qualified employees and key personnel;



our ability to maintain good working relationships with our employees, and avoid labor disruptions, strikes and other disputes with labor unions that represent certain of our employees; and



the potential impact of one or more of our customers becoming bankrupt or insolvent, or experiencing other financial problems.

•

~~the potential impact of the Coronavirus on our business and results of operations;~~

•

~~growth of the wind energy market and our addressable market;~~

•

~~the potential impact of the increasing prevalence of auction-based tenders in the wind energy market and increased competition from solar energy on our gross margins and overall financial performance;~~

•

~~changes in domestic or international government or regulatory policy, including without limitation, changes in trade policy;~~

•

~~the sufficiency of our cash and cash equivalents to meet our liquidity needs;~~

•

~~our ability to attract and retain customers for our products, and to optimize product pricing;~~

•

~~our ability to effectively manage our growth strategy and future expenses, including our startup and transition costs;~~

•

~~competition from other wind blade and wind blade turbine manufacturers;~~

•

~~the discovery of defects in our products and our ability to estimate the future cost of warranty campaigns and product recalls;~~

•

~~our ability to successfully open new manufacturing facilities and expand existing facilities on time and on budget;~~

•

~~the impact of the accelerated pace of new product and wind blade model introductions on our business and our results of operations;~~

•

~~our ability to successfully expand our transportation business and execute upon our strategy of entering new markets outside of wind energy;~~

•

~~worldwide economic conditions and their impact on customer demand;~~

•

~~our ability to maintain, protect and enhance our intellectual property;~~

•

~~our ability to comply with existing, modified or new laws and regulations applying to our business, including the imposition of new taxes, duties or similar assessments on our products;~~

•

~~the attraction and retention of qualified employees and key personnel;~~

•

~~our ability to maintain good working relationships with our employees, and avoid labor disruptions, strikes and other disputes with labor unions that represent certain of our employees;~~

•

~~our ability to procure adequate supplies of raw materials and components to fulfill our wind blade volume commitments to our customers; and~~

•

~~the potential impact of one or more of our customers becoming bankrupt or insolvent, or experiencing other financial problems.~~

These forward-looking statements are only predictions. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to materially differ from any future results, levels of activity, performance or achievements expressed or

implied by these forward-looking statements. We have described in the “Risk Factors” section of our Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on ~~March 2, 2020~~February 25, 2021 the principal risks and uncertainties that

we believe could cause actual results to differ from these forward-looking statements. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as guarantees of future events.

The forward-looking statements in this Quarterly Report on Form 10-Q represent our views as of the date of this Quarterly Report on Form 10-Q. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we undertake no obligation to update any forward-looking statement to reflect events or developments after the date on which the statement is made or to reflect the occurrence of unanticipated events except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date after the date of this Quarterly Report on Form 10-Q. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

PART I—I. FINANCIAL INFORMATION

ITEM l. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


	September 30,			December 31,			September 30,			December 31,
	2020			2019			2021			2020
	(in thousands, except par value data)						(in thousands, except par value data)
Assets
Current assets:
Cash and cash equivalents	$	149,422		$	70,282		$	119,005		$	129,857
Restricted cash		1,987			992			153			339
Accounts receivable		149,985			184,012			178,104			132,768
Contract assets		211,569			166,515			244,774			216,928
Prepaid expenses		15,950			10,047			22,916			29,507
Other current assets		21,794			29,843			22,613			27,921
Inventories		14,569			6,731			11,251			10,839
Total current assets		565,276			468,422			598,816			548,159
Property, plant, and equipment, net		210,024			205,007
Property, plant and equipment, net								192,326			209,001
Operating lease right of use assets		168,590			122,351			146,794			158,827
Other noncurrent assets		41,794			30,897			24,653			40,270
Total assets	$	985,684		$	826,677		$	962,589		$	956,257

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses	$	310,344		$	293,104		$	346,272		$	295,992
Accrued warranty		53,596			47,639			42,479			50,852
Current maturities of long-term debt		35,788			13,501			251,563			32,551
Current operating lease liabilities		25,569			16,629			22,939			26,099
Contract liabilities		2,010			3,008			0			614
Total current liabilities		427,307			373,881			663,253			406,108
Long-term debt, net of debt issuance costs and current maturities		201,780			127,888
Long-term debt, net of current maturities								10,566			184,316
Noncurrent operating lease liabilities		165,551			113,883			149,742			155,925
Other noncurrent liabilities		9,594			5,975			7,964			8,873
Total liabilities		804,232			621,627			831,525			755,222
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common shares, $0.01 par value, 100,000 shares authorized, 35,916 shares issued and 35,740 shares outstanding at September 30, 2020 and 100,000 shares authorized, 35,326 shares issued and 35,181 shares outstanding at December 31, 2019		359			353
Common shares, $0.01 par value, 100,000 shares authorized, 37,279 shares issued and 37,071 shares outstanding at September 30, 2021 and 100,000 shares authorized, 36,771 shares issued and 36,564 shares outstanding at December 31, 2020								373			368
Paid-in capital		338,355			322,906			361,987			349,472
Accumulated other comprehensive loss		(37,946	)		(23,612	)		(43,176	)		(32,990	)
Accumulated deficit		(114,900	)		(90,689	)		(181,987	)		(109,716	)
Treasury stock, at cost, 176 shares at September 30, 2020 and 145 shares at December 31, 2019		(4,416	)		(3,908	)
Treasury stock, at cost, 208 shares at September 30, 2021 and 207 shares at December 31, 2020								(6,133	)		(6,099	)
Total stockholders’ equity		181,452			205,050			131,064			201,035
Total liabilities and stockholders’ equity	$	985,684		$	826,677		$	962,589		$	956,257

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended						Nine Months Ended						Three Months Ended						Nine Months Ended
	September 30,						September 30,						September 30,						September 30,
	2020			2019			2020			2019			2021			2020			2021			2020
	(in thousands, except per share data)												(in thousands, except per share data)
Net sales	$	474,113		$	383,836		$	1,204,566		$	1,014,387		$	479,599		$	474,113		$	1,343,120		$	1,204,566
Cost of sales		425,064			335,778			1,141,183			904,135			472,188			425,064			1,295,660			1,141,183
Startup and transition costs		8,576			22,127			31,530			63,206			14,541			8,576			38,994			31,530
Total cost of goods sold		433,640			357,905			1,172,713			967,341			486,729			433,640			1,334,654			1,172,713
Gross profit		40,473			25,931			31,853			47,046
Gross profit (loss)														(7,130	)		40,473			8,466			31,853
General and administrative expenses		9,263			10,608			25,646			27,801			8,185			9,263			23,819			25,646
Realized loss on sale of assets and asset impairments		2,160			3,354			5,518			10,561
Restructuring charges (reversals), net		45			(149	)		343			3,725
Income from operations		29,005			12,118			346			4,959
Loss on sale of assets and asset impairments														7,250			2,160			9,998			5,518
Restructuring charges, net														1,422			45			3,876			343
Income (loss) from operations														(23,987	)		29,005			(29,227	)		346
Other income (expense):
Interest income		15			43			55			125
Interest expense		(3,108	)		(2,130	)		(7,464	)		(6,403	)
Realized gain (loss) on foreign currency remeasurement		(17,127	)		3,719			(18,095	)		(1,050	)
Interest expense, net														(2,662	)		(3,093	)		(8,057	)		(7,409	)
Foreign currency income (loss)														3,958			(17,127	)		(6,273	)		(18,095	)
Miscellaneous income		1,259			517			2,893			2,235			262			1,259			1,322			2,893
Total other income (expense)		(18,961	)		2,149			(22,611	)		(5,093	)		1,558			(18,961	)		(13,008	)		(22,611	)
Income (loss) before income taxes		10,044			14,267			(22,265	)		(134	)		(22,429	)		10,044			(42,235	)		(22,265	)
Income tax benefit (provision)		32,338			(18,838	)		(1,946	)		(14,713	)		(8,248	)		32,338			(30,036	)		(1,946	)
Net income (loss)	$	42,382		$	(4,571	)	$	(24,211	)	$	(14,847	)	$	(30,677	)	$	42,382		$	(72,271	)	$	(24,211	)

Weighted-average common shares outstanding:
Basic		35,546			35,131			35,354			35,024			37,052			35,546			36,846			35,354
Diluted		37,423			35,131			35,354			35,024			37,052			37,423			36,846			35,354

Net income (loss) per common share:
Basic	$	1.19		$	(0.13	)	$	(0.68	)	$	(0.42	)	$	(0.83	)	$	1.19		$	(1.96	)	$	(0.68	)
Diluted	$	1.13		$	(0.13	)	$	(0.68	)	$	(0.42	)	$	(0.83	)	$	1.13		$	(1.96	)	$	(0.68	)

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)


	Three Months Ended						Nine Months Ended						Three Months Ended						Nine Months Ended
	September 30,						September 30,						September 30,						September 30,
	2020			2019			2020			2019			2021			2020			2021			2020
	(in thousands)												(in thousands)
Net income (loss)	$	42,382		$	(4,571	)	$	(24,211	)	$	(14,847	)	$	(30,677	)	$	42,382		$	(72,271	)	$	(24,211	)
Other comprehensive income (loss):
Foreign currency translation adjustments		(1,662	)		(895	)		(13,175	)		(3,765	)		(889	)		(1,662	)		(6,184	)		(13,175	)
Unrealized gain (loss) on hedging derivatives, net of taxes of $(1,100), $202, $0, and $967, respectively		2,961			(754	)		(1,159	)		(3,635	)
Unrealized gain (loss) on hedging derivatives, net of taxes of $(394), $(1,100), $342 and $0, respectively														(728	)		2,961			(4,002	)		(1,159	)
Comprehensive income (loss)	$	43,681		$	(6,220	)	$	(38,545	)	$	(22,247	)	$	(32,294	)	$	43,681		$	(82,457	)	$	(38,545	)

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

Nine Months Ended September 30, 2020

Accumulated

Common

Paid-in

other comprehensive

Accumulated

Treasury stock,

Total stockholders'

Shares

Amount

capital

loss

deficit

at cost

equity

(in thousands)

Balance at December 31, 2019

35,326

$
353

$
322,906

$
(23,612
)

$
(90,689
)

$
(3,908
)

$
205,050

Net loss

—

—

—

—

(492
)

—

(492
)
Share-based compensation expense

—

—

2,970

—

—

—

2,970

Issuances under share-based compensation
plan

109

1

861

—

—

—

862

Common stock repurchased for treasury

—

—

—

—

—

(459
)

(459
)
Other comprehensive loss

—

—

—

(16,893
)

—

—

(16,893
)
Balance at March 31, 2020

35,435

354

326,737

(40,505
)

(91,181
)

(4,367
)

191,038

Net loss

—

—

—

—

(66,101
)

—

(66,101
)
Share-based compensation expense

—

—

2,186

—

—

—

2,186

Issuances under share-based compensation
plan

81

1

510

—

—

—

511

Common stock repurchased for treasury

—

—

—

—

—

(49
)

(49
)
Other comprehensive income

—

—

—

1,260

—

—

1,260

Balance at June 30, 2020

35,516

355

329,433

(39,245
)

(157,282
)

(4,416
)

128,845

Net income

—

—

—

—

42,382

—

42,382

Share-based compensation expense

—

—

2,434

—

—

—

2,434

Issuances under share-based compensation
plan

395

4

6,488

—

—

—

6,492

Other comprehensive income

—

—

—

1,299

—

—

1,299

Balance at September 30, 2020

35,911

$
359

$
338,355

$
(37,946
)

$
(114,900
)

$
(4,416
)

$
181,452


	Nine Months Ended September 30, 2021
							Accumulated
	Common				Paid-in		other comprehensive			Accumulated			Treasury stock,			Total stockholders'
	Shares		Amount		capital		loss			deficit			at cost			equity
	(in thousands)
Balance at December 31, 2020		36,771	$	368	$	349,472	$	(32,990	)	$	(109,716	)	$	(6,099	)	$	201,035
Net loss		—		—		—		—			(1,797	)		—			(1,797	)
Share-based compensation expense		—		—		2,494		—			—			—			2,494
Issuances under share- based compensation plan		149		1		1,235		—			—			—			1,236
Common stock repurchased for treasury		—		—		—		—			—			(34	)		(34	)
Other comprehensive loss		—		—		—		(8,326	)		—			—			(8,326	)
Balance at March 31, 2021		36,920		369		353,201		(41,316	)		(111,513	)		(6,133	)		194,608
Net loss		—		—		—		—			(39,797	)		—			(39,797	)
Share-based compensation expense		—		—		2,836		—			—			—			2,836
Issuances under share- based compensation plan		328		3		3,490		—			—			—			3,493
Other comprehensive loss		—		—		—		(243	)		—			—			(243	)
Balance at June 30, 2021		37,248		372		359,527		(41,559	)		(151,310	)		(6,133	)		160,897
Net loss		—		—		—		—			(30,677	)		—			(30,677	)
Share-based compensation expense		—		—		1,946		—			—			—			1,946
Issuances under share- based compensation plan		31		1		514		—			—			—			515
Other comprehensive loss		—		—		—		(1,617	)		—			—			(1,617	)
Balance at September 30, 2021		37,279	$	373	$	361,987	$	(43,176	)	$	(181,987	)	$	(6,133	)	$	131,064

~~See accompanying notes to unaudited condensed consolidated financial statements.~~7

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - CONTINUED

(Unaudited)

Nine Months Ended September 30, 2019

Accumulated

Common

Paid-in

other comprehensive

Accumulated

Treasury stock,

Total stockholders'

Shares

Amount

capital

loss

deficit

at cost

equity

(in thousands)

Balance at December 31, 2018

34,745

$
347

$
311,771

$
(14,392
)

$
(74,981
)

$
(1,788
)

$
220,957

Net loss

—

—

—

—

(12,104
)

—

(12,104
)
Share-based compensation expense

—

—

821

—

—

—

821

Issuances under share-based compensation
plan

355

4

4,635

—

—

—

4,639

Common stock repurchased for treasury

—

—

—

—

—

(559
)

(559
)
Other comprehensive loss

—

—

—

(477
)

—

—

(477
)
Balance at March 31, 2019

35,100

351

317,227

(14,869
)

(87,085
)

(2,347
)

213,277

Net income

—

—

—

—

1,828

—

1,828

Share-based compensation expense

—

—

2,057

—

—

—

2,057

Issuances under share-based compensation
plan

41

—

144

—

—

—

144

Other comprehensive loss

—

—

—

(5,274
)

—

—

(5,274
)
Balance at June 30, 2019

35,141

351

319,428

(20,143
)

(85,257
)

(2,347
)

212,032

Net loss

—

—

—

—

(4,571
)

—

(4,571
)
Share-based compensation expense

—

—

1,905

—

—

—

1,905

Issuances under share-based compensation
plan

158

2

7

—

—

—

9

Common stock repurchased for treasury

—

—

—

—

—

(1,561
)

(1,561
)
Other comprehensive loss

—

—

—

(1,649
)

—

—

(1,649
)
Balance at September 30, 2019

35,299

$
353

$
321,340

$
(21,792
)

$
(89,828
)

$
(3,908
)

$
206,165


	Nine Months Ended September 30, 2020
							Accumulated
	Common				Paid-in		other comprehensive			Accumulated			Treasury stock,			Total stockholders'
	Shares		Amount		capital		loss			deficit			at cost			equity
	(in thousands)
Balance at December 31, 2019		35,326	$	353	$	322,906	$	(23,612	)	$	(90,689	)	$	(3,908	)	$	205,050
Net loss		—		—		—		—			(492	)		—			(492	)
Share-based compensation expense		—		—		2,970		—			—			—			2,970
Issuances under share- based compensation plan		109		1		861		—			—			—			862
Common stock repurchased for treasury		—		—		—		—			—			(459	)		(459	)
Other comprehensive loss		—		—		—		(16,893	)		—			—			(16,893	)
Balance at March 31, 2020		35,435		354		326,737		(40,505	)		(91,181	)		(4,367	)		191,038
Net loss		—		—		—		—			(66,101	)		—			(66,101	)
Share-based compensation expense		—		—		2,186		—			—			—			2,186
Issuances under share- based compensation plan		81		1		510		—			—			—			511
Common stock repurchased for treasury		—		—		—		—			—			(49	)		(49	)
Other comprehensive income		—		—		—		1,260			—			—			1,260
Balance at June 30, 2020		35,516		355		329,433		(39,245	)		(157,282	)		(4,416	)		128,845
Net income		—		—		—		—			42,382			—			42,382
Share-based compensation expense		—		—		2,434		—			—			—			2,434
Issuances under share- based compensation plan		395		4		6,488		—			—			—			6,492
Other comprehensive income		—		—		—		1,299			—			—			1,299
Balance at September 30, 2020		35,911	$	359	$	338,355	$	(37,946	)	$	(114,900	)	$	(4,416	)	$	181,452

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended						Nine Months Ended
	September 30,						September 30,
	2020			2019			2021			2020
	(in thousands)						(in thousands)
Cash flows from operating activities:
Net loss	$	(24,211	)	$	(14,847	)	$	(72,271	)	$	(24,211	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		36,675			27,732			37,399			36,675
Realized loss on sale of assets and asset impairments		5,518			10,561
Restructuring charges, net		343			3,725
Loss on sale of assets and asset impairments								9,998			5,518
Share-based compensation expense		7,947			4,604			7,267			7,947
Amortization of debt issuance costs		237			155			342			237
Deferred income taxes		(9,375	)		3,296			17,201			(9,375	)
Changes in assets and liabilities:
Accounts receivable		27,723			15,583			(51,617	)		27,723
Contract assets and liabilities		(48,185	)		(55,952	)		(31,715	)		(48,185	)
Operating lease right of use assets and operating lease liabilities		14,370			3,511			2,690			14,370
Inventories		(7,986	)		(6,044	)		(560	)		(7,986	)
Prepaid expenses		(6,066	)		(10,419	)		6,288			(6,066	)
Other current assets		7,827			(10,296	)		5,007			7,827
Other noncurrent assets		338			(5,178	)		(1,857	)		338
Accounts payable and accrued expenses		19,167			82,421			52,869			19,510
Accrued warranty		5,957			11,517			(8,373	)		5,957
Other noncurrent liabilities		3,586			2,366			(909	)		3,586
Net cash provided by operating activities		33,865			62,735
Net cash provided by (used in) operating activities								(28,241	)		33,865
Cash flows from investing activities:
Purchases of property, plant and equipment		(53,428	)		(59,092	)		(30,138	)		(53,428	)
Acquisition of a business		—			(1,102	)
Net cash used in investing activities		(53,428	)		(60,194	)		(30,138	)		(53,428	)
Cash flows from financing activities:
Proceeds from revolving loans		80,000			16,000
Repayments of revolving loans		(7,199	)		—
Proceeds from revolving and term loans								18,109			80,000
Repayments of revolving and term loans								0			(7,199	)
Net repayments of accounts receivable financing		(3,979	)		(5,415	)		0			(3,979	)
Proceeds from working capital loans		—			3,535			10,334			0
Repayments of working capital loans		—			(2,828	)
Principal repayments of finance leases		(4,592	)		(7,621	)		(4,249	)		(4,592	)
Net proceeds (repayments) of other debt		32,311			(3,919	)
Net proceeds from other debt								18,909			32,311
Debt issuance costs		(730	)		—			0			(730	)
Proceeds from exercise of stock options		7,124			4,726			5,211			7,124
Repurchase of common stock including shares withheld in lieu of income taxes		(508	)		(2,120	)		(34	)		(508	)
Net cash provided by financing activities		102,427			2,358			48,280			102,427
Impact of foreign exchange rates on cash, cash equivalents and restricted cash		(3,204	)		(115	)		(939	)		(3,204	)
Net change in cash, cash equivalents and restricted cash		79,660			4,784			(11,038	)		79,660
Cash, cash equivalents and restricted cash, beginning of year		71,749			89,376			130,196			71,749
Cash, cash equivalents and restricted cash, end of period	$	151,409		$	94,160		$	119,158		$	151,409

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

(Unaudited)


	Nine Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2021		2020
	(in thousands)				(in thousands)
Supplemental cash flow information:
Cash paid for interest	$	6,871	$	6,397	$	7,818	$	6,871
Cash paid for income taxes, net of refunds		11,642		15,033		19,487		11,642
Noncash investing and financing activities:
Right of use assets obtained in exchange for new operating lease liabilities		67,705		12,205		9,190		67,705
Property, plant, and equipment obtained in exchange for new finance lease liabilities		131		5,122		1,817		131
Accrued capital expenditures in accounts payable		7,769		6,594		4,966		7,769


Reconciliation of Cash, Cash Equivalents and Restricted Cash:	September 30,		December 31,		September 30,		December 31,		September 30,		December 31,		September 30,		December 31,
	2020		2019		2019		2018		2021		2020		2020		2019
	(in thousands)								(in thousands)
Condensed Consolidated Balance Sheets
Cash and cash equivalents	$	149,422	$	70,282	$	92,085	$	85,346	$	119,005	$	129,857	$	149,422	$	70,282
Restricted cash		1,987		992		1,600		3,555		153		339		1,987		992
Restricted cash included within other noncurrent assets		—		475		475		475		0		0		0		475
Condensed Consolidated Statements Of Cash Flows
Total cash, cash equivalents and restricted cash	$	151,409	$	71,749	$	94,160	$	89,376
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows									$	119,158	$	130,196	$	151,409	$	71,749

See accompanying notes to unaudited condensed consolidated financial statements.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Basis of Presentation ~~and Recently Issued Accounting Pronouncements~~

~~Basis of Presentation~~

The condensed consolidated financial statements included herein have been prepared by us without audit, pursuant to the rules and regulations of the SEC and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, ~~2019~~2020 included in our Annual Report on Form 10-K. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (GAAP) have been condensed or omitted, as permitted by the SEC, although we believe the disclosures that are made are adequate to make the information presented herein not misleading. The accompanying condensed consolidated financial statements reflect, in the opinion of our management, all normal recurring adjustments necessary to present fairly our financial position at September 30, ~~2020,~~2021, and the results of our operations, comprehensive income (loss) and cash flows for the periods presented. Interim results for the three and nine months ended September 30, ~~2020~~2021 and ~~2019~~2020 are not necessarily indicative of the results to be expected for the full years. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation.

The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The accompanying condensed consolidated financial statements include the accounts of TPI Composites, Inc. and all of our majority owned subsidiaries. All significant intercompany transactions and balances have been eliminated.

References to TPI Composites, Inc, the “Company,” “we,” “us” or “our” in these notes refer to TPI Composites, Inc. and its consolidated subsidiaries.

~~Recently Issued~~ Accounting Pronouncements

Recently Adopted Accounting Pronouncements ~~Adopted in~~

Convertible Instruments

In August 2020,

~~Financial Instruments~~

~~In June 2016,~~ the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) ~~No. 2016-13,~~ 2020-06, ~~Financial~~Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments ~~– Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments~~and Contracts in an Entity’s Own Equity.~~. The new standard~~ This ASU is intended to ~~provide financial statement users~~simplify the accounting for certain convertible instruments with ~~more decision-useful information about~~characteristics of both liability and equity. This ASU removes certain accounting models which separate the ~~expected credit losses on financial~~embedded conversion features from the host contract for convertible instruments. As a result, after the adoption of this guidance, an entity’s convertible debt instrument will be wholly accounted for as debt. This ASU also expands disclosure requirements for convertible instruments and ~~other commitments to extend credit held at each reporting date.~~ simplifies areas of the guidance for diluted earnings-per-share calculations by requiring the use of the if-converted method.

This ~~standard was~~ASU is effective for all public business entities (other than smaller reporting companies) for ~~annual and interim periods~~fiscal years beginning after December 15, ~~2019,~~2021, with early adoption ~~permitted.~~permitted for fiscal years beginning after December 15, 2020 and can be adopted on either a fully retrospective or modified retrospective basis. An entity should adopt the guidance at the beginning of its annual fiscal year. We adopted this standard on January 1, ~~2020~~2021 on a modified retrospective basis and it did not have a material effect on our condensed consolidated financial statements.

~~Fair Value Measurement~~

~~In August 2018, the FASB issued ASU 2018-13,~~ ~~Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements in Topic 820.~~

This standard was effective for all public business entities for annual and interim periods beginning after December 15, 2019, with early adoption permitted. We adopted this standard on January 1, 2020 and it did not have a material effect on our condensed consolidated financial statements.

~~Income Taxes~~

~~In December 2019, the FASB issued ASU 2019-12,~~ ~~Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,~~ which primarily removes specific exemptions to the general principles in Topic 740 in GAAP and improves the financial statement preparers’ application of income tax-related guidance and simplifies GAAP.

~~We adopted this standard on January 1, 2020 and it did not have a material effect on our condensed consolidated financial statements.~~

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Recently Issued Accounting Pronouncements ~~Not Yet Adopted~~

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04,, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting~~. The amendments provide optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance~~, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ~~The amendments apply~~This ASU only applies to contracts, ~~and~~ hedging relationships, and other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued ~~due to~~because of reference rate reform. ~~These amendments are~~This ASU is effective ~~immediately~~for all entities beginning on March 12, 2020 and entities may ~~be applied~~elect to apply the ASU prospectively ~~to contract modifications made and hedging relationships entered into or evaluated on or before~~through December 31, 2022. The FASB later issued ASU 2021-01, Reference Rate

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Reform (Topic 848): Scope, to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. We are currently evaluating the impact this guidance may have on our ~~contracts~~condensed consolidated financial statements and ~~the optional expedients provided by the new standard.~~related disclosures.

Note 2. Revenue From Contracts with Customers

For a detailed discussion of our revenue recognition policy, refer to the discussion in Note 1, Summary of Operations and Summary of Significant Accounting Policies – (c) Revenue Recognition, to the Notes to Consolidated Financial Statements within our Annual Report on Form 10-K.

The following tables represents the disaggregation of our net sales revenue by product for each of our reportable segments:


	Three Months Ended September 30, 2020										Three Months Ended September 30, 2021
	U.S.		Asia		Mexico		EMEAI		Total		U.S.		Asia		Mexico		EMEA		India		Total
	(in thousands)										(in thousands)
Wind blade sales	$	37,272	$	158,120	$	153,575	$	101,168	$	450,135	$	35,154	$	47,187	$	191,499	$	126,705	$	50,180	$	450,725
Precision molding and assembly systems sales		—		4,451		6,090		—		10,541		0		3,869		4,514		0		0		8,383
Transportation sales		6,206		—		801		—		7,007		3,621		0		3,194		0		0		6,815
Other sales		3,321		887		1,097		1,125		6,430		8,927		813		1,125		2,739		72		13,676
Total net sales	$	46,799	$	163,458	$	161,563	$	102,293	$	474,113	$	47,702	$	51,869	$	200,332	$	129,444	$	50,252	$	479,599


	Three Months Ended September 30, 2020
	U.S.		Asia		Mexico		EMEA		India		Total
	(in thousands)
Wind blade sales	$	37,272	$	158,120	$	153,575	$	82,550	$	18,618	$	450,135
Precision molding and assembly systems sales		0		4,451		6,090		0		0		10,541
Transportation sales		6,206		0		801		0		0		7,007
Other sales		3,321		887		1,097		1,090		35		6,430
Total net sales	$	46,799	$	163,458	$	161,563	$	83,640	$	18,653	$	474,113


	Nine Months Ended September 30, 2021
	U.S.		Asia		Mexico		EMEA		India		Total
	(in thousands)
Wind blade sales	$	114,208	$	202,181	$	431,129	$	340,933	$	160,157	$	1,248,608
Precision molding and assembly systems sales		0		15,467		15,446		0		0		30,913
Transportation sales		22,272		0		7,589		0		0		29,861
Other sales		17,269		2,255		7,797		6,227		190		33,738
Total net sales	$	153,749	$	219,903	$	461,961	$	347,160	$	160,347	$	1,343,120


	Nine Months Ended September 30, 2020
	U.S.		Asia		Mexico		EMEA		India		Total
	(in thousands)
Wind blade sales	$	99,514	$	385,536	$	346,954	$	258,193	$	44,338	$	1,134,535
Precision molding and assembly systems sales		0		13,088		11,110		0		0		24,198
Transportation sales		27,424		0		1,374		0		0		28,798
Other sales		9,371		1,889		3,795		1,945		35		17,035
Total net sales	$	136,309	$	400,513	$	363,233	$	260,138	$	44,373	$	1,204,566

Three Months Ended September 30, 2019

U.S.

Asia

Mexico

EMEAI

Total

(in thousands)

Wind blade sales

$
25,857

$
98,406

$
111,855

$
116,084

$
352,202

Precision molding and
assembly systems sales

1,479

8,915

4,655

—

15,049

Transportation sales

8,061

—

—

—

8,061

Other sales

5,246

793

1,180

1,305

8,524

Total net sales

$
40,643

$
108,114

$
117,690

$
117,389

$
383,836

For a further discussion regarding our operating segments, see Note 14, Segment Reporting. The geographic regions of Europe, the Middle East and Africa comprises the EMEA segment.

Nine Months Ended September 30, 2020

U.S.

Asia

Mexico

EMEAI

Total

(in thousands)

Wind blade sales

$
99,514

$
385,536

$
346,954

$
302,531

$
1,134,535

Precision molding and
assembly systems sales

—

13,088

11,110

—

24,198

Transportation sales

27,424

—

1,374

—

28,798

Other sales

9,371

1,889

3,795

1,980

17,035

Total net sales

$
136,309

$
400,513

$
363,233

$
304,511

$
1,204,566

1312

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Nine Months Ended September 30, 2019

U.S.

Asia

Mexico

EMEAI

Total

(in thousands)

Wind blade sales

$
84,328

$
238,947

$
278,685

$
328,956

$
930,916

Precision molding and
assembly systems sales

2,845

20,856

15,475

—

39,176

Transportation sales

20,717

—

—

—

20,717

Other sales

14,239

1,728

3,557

4,054

23,578

Total net sales

$
122,129

$
261,531

$
297,717

$
333,010

$
1,014,387

~~Most of our net sales are made directly to our customers, primarily large multi-national wind turbine manufacturers, under our long-term contracts which are typically five years in length.~~

Contract Assets and Liabilities

Contract assets consist of the amount of revenue recognized over time for performance obligations in production where control has transferred to the customer but the contract does not yet allow for the customer to be billed. Typically, customers are billed when the product finishes production and meets the technical specifications contained in the contract. The ~~time it takes~~majority of the contract asset balance relates to ~~produce a single blade is typically between 5 to 7 days. The time it takes to produce a mold is typically between 3 to 6 months.~~materials procured based on customer specifications. The contract assets are recorded as current assets in the condensed consolidated balance sheets. Contract liabilities consist of advance payments in excess of revenue earned. These amounts ~~were historically recorded as customer deposits which usually relate to~~primarily represent progress payments received as precision molding and assembly systems ~~were~~are being manufactured. The contract liabilities are recorded as current liabilities in the condensed consolidated balance sheets and are reduced as we record revenue over time.

These contract assets and liabilities are reported on the condensed consolidated balance sheets net on a contract-by-contract basis at the end of each reporting ~~period, as demonstrated in the table below.~~period.

Contract assets and contract liabilities consisted of the following:


	September 30,			December 31,
	2021			2020			$ Change
	(in thousands)
Gross contract assets	$	253,878		$	223,428		$	30,450
Less: reclassification from contract liabilities		(9,104	)		(6,500	)		(2,604	)
Contract assets	$	244,774		$	216,928		$	27,846

September 30,

December 31,

2020

2019

$ Change

(in thousands)

Gross contract assets

$
214,586

$
170,973

$
43,613

Less: reclassification from contract liabilities

(3,017
)

(4,458
)

1,441

Contract assets

$
211,569

$
166,515

$
45,054


	September 30,			December 31,
	2021			2020			$ Change
	(in thousands)
Gross contract liabilities	$	9,104		$	7,114		$	1,990
Less: reclassification to contract assets		(9,104	)		(6,500	)		(2,604	)
Contract liabilities	$	0		$	614		$	(614	)

September 30,

December 31,

2020

2019

$ Change

(in thousands)

Gross contract liabilities

$
5,027

$
7,466

$
(2,439
)
Less: reclassification to contract assets

(3,017
)

(4,458
)

1,441

Contract liabilities

$
2,010

$
3,008

$
(998
)

Contract assets increased by ~~$45.1~~$27.8 million from December 31, ~~2019~~2020 to September 30, ~~2020~~2021 due to an increase in customer specific material purchases and incremental unbilled production ~~which includes materials acquired under long-term contracts,~~ during the nine months ended September 30, ~~2020.~~2021. Contracts liabilities decreased by ~~$1.0~~$0.6 million from December 31, ~~2019~~2020 to September 30, ~~2020~~2021 primarily due to the revenue earned related to precision molding and assembly systems and wind blades being produced exceeding the amounts billed to customers induring the nine months ended September 30, ~~2020.~~2021.

For the three and nine months ended September 30, ~~2020,~~2021, we recognized ~~0 revenue~~$0.5 million and ~~$3.0~~$0.6 million, respectively, of revenue ~~respectively,~~ related to precision molding and assembly systems and wind blades, which ~~were~~was included in the corresponding contract liability balance at the beginning of the period.

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Performance Obligations

Remaining performance obligations represent the transaction price for which work has not been performed and excludes any unexercised contract options. The transaction price includes estimated variable consideration as determined based on the estimated production output within the range of the contractual guaranteed minimum volume obligations and production capacity.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

As of September 30, ~~2020,~~2021, the aggregate amount of the transaction price allocated to the remaining performance obligations to be satisfied in future periods was approximately ~~$3.8~~$3.1 billion. We estimate that we will recognize ~~these~~the remaining performance obligations as revenue as follows:

$

% of Total

(in thousands)

Year Ending December 31,

Remainder of 2020

$
448,348

11.9
%
2021

1,609,674

42.5
%
2022

1,095,947

29.0
%
2023

554,245

14.6
%
2024

75,954

2.0
%
Total remaining performance obligations

$
3,784,168

100.0
%


	$		% of Total
	(in thousands)
Year Ending December 31,
Remainder of 2021	$	418,708		13.4	%
2022		1,632,634		52.1
2023		898,126		28.6
2024		186,034		5.9
Total remaining performance obligations	$	3,135,502		100.0	%

The transaction price allocated to the remaining performance obligations excludes approximately $178.0 million of variable consideration over the contractual guaranteed minimum volume obligations under current contracts with customers which has been constrained primarily due to uncertainty associated with production volume during the remaining term of the agreements. We estimate the constraint will be resolved in subsequent periods when our customers provide additional information relevant to forecasted future production.

For the three and nine months ended September 30, ~~2020,~~2021, net revenue recognized from our performance obligations satisfied in previous periods ~~increased~~decreased by ~~$14.8~~$7.3 million and ~~$15.4~~$19.8 million, respectively, as compared to ~~decreases~~increases of ~~$3.5~~$14.8 million and ~~$16.0~~$15.4 million, respectively, in the same periods ~~of 2019.~~in 2020. The current year ~~increase~~decreases primarily ~~related~~relates to changes in certain of our estimated total contract values and related direct costs to complete the performance obligations.

Note 3. Significant Risks and Uncertainties

Our revenues and receivables are earned from a small number of customers. As such, our production levels are dependent on these customers’ orders. See Note 13, Concentration of Customers.

The COVID-19 pandemic adversely impacted our operations and results of operations for the nine months ended September 30, 2020 due to reduced production levels at a majority of our manufacturing facilities primarily during the first and second quarters of 2020 as a result of certain applicable government-mandated stay at home orders in response to the COVID-19 pandemic, demands from certain of our labor unions to suspend or reduce production and general safety concerns of our associates. By the end of the second quarter of 2020, most of our manufacturing facilities had returned to operating at or near normal production levels. For the third quarter of 2020, the COVID-19 pandemic did not have a material adverse impact on our operations and results of operations.

~~However, several of our manufacturing facilities are operating in regions with high levels of reported COVID-19 positive cases. As such, we~~We may be required to reinstate temporary production suspensions or volume reductions at ~~these manufacturing facilities or at~~ our ~~other~~ manufacturing facilities to the extent there ~~is a resurgence~~are new resurgences of COVID-19 cases in the regions where we operate or there is an outbreak of positive COVID-19 cases in any of our manufacturing facilities. For example, during the three months ended September 30, 2021 our manufacturing facility in Yangzhou, China was shut down for approximately three weeks due to a small outbreak of positive COVID-19 cases in Yangzhou City. In addition, our global supply chain has been adversely affected by the COVID-19 pandemic during 2021 and may continue to be adversely affected if the COVID-19 pandemic persists.

During 2021, there have been both significant price increases and supply constraints with respect to resin and carbon fiber, which are key raw materials that we use to manufacture our products, as well as increases in logistics costs to obtain raw materials. We expect that the price of resin and carbon fiber will remain at elevated levels for the remainder of 2021. Approximately 55% of the resin and resin systems we use are purchased under contracts either controlled or borne by 2 of our customers and therefore these customers receive/bear 100% of any decrease or increase in resin prices. With respect to our other customer supply agreements, our customers typically receive/bear 70% of any raw material price decreases or increases. If the supply of resin feedstocks and carbon fiber continue to be constrained for an extended period of time, such shortages could impact our ability to meet our customers’ forecasted demand for our products for the remainder of 2021 and have a further material adverse impact on our results of operations for the remainder of 2021.

We maintain our U.S. cash in bank deposit and money market accounts that, at times, exceed U.S. federally insured limits. U.S. bank accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) in an amount up to ~~$250,000~~$250,000 during ~~2020~~2021 and ~~2019.~~2020. U.S. money market accounts are not guaranteed by the FDIC. At September 30, ~~2020~~2021 and December 31, ~~2019,~~2020, we had ~~$76.0~~$70.5 million and ~~$45.8~~$68.9 million, respectively, of cash in bank deposit and money market accounts in U.S. banks, which was in excess of FDIC limits. We have not experienced losses in any such accounts.

We also maintain cash in bank deposit accounts outside the U.S. with no insurance. At September 30, ~~2020,~~2021, this included ~~$47.2~~$20.7 million in China, ~~$18.8~~$17.9 million in Turkey, ~~$6.2~~$7.3 million in India, ~~$1.0~~$1.9 million in Mexico and ~~$0.2~~$0.7 million in other countries. As of December 31, 2020, this included $47.4 million in China, $6.0 million in Turkey, $5.0 million in India, $2.1 million in Mexico and $0.5 million in other countries. We have

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

not experienced losses in these accounts. In addition, at September 30, 2021 and December 31, 2020, we had short-term deposits in interest bearing accounts ~~of $1.7 million in the U.S., and $0.3 million~~ in China of $0.2 million and $0.3 million, respectively, which are reported as restricted cash in our condensed consolidated balance sheets.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Certain of our debt agreements are either tied to LIBOR or the Euro Interbank Offered Rate (EURIBOR) and certain of them have associated interest rate hedges. Due to the relatively low LIBOR and EURIBOR rates in effect as of September 30, 2021, a 10% change in the LIBOR or EURIBOR rate would not have had a material impact on our future earnings, fair values or cash flows.

Note 4. Accrued Warranty

We provide a limited warranty for our wind blades and related precision molding and assembly systems, including materials and workmanship, with terms and conditions that vary depending on the product sold, generally for periods that range from two to five years. We also provide a limited warranty for our transportation products, including materials and workmanship, with terms and conditions that vary depending on the product sold, generally for a period of approximately two years. Warranty expense is recorded based upon estimates of future repairs using a probability-based methodology that considers previous warranty claims, identified quality issues and industry practices. Once the warranty period has expired, any remaining unused warranty accrual for the specific products is generally reversed against the current year warranty expense amount. As of September 30, 2020, a change in the estimated warranty accrual rate of 1% across all products would change the warranty accrual by approximately $39.5 million.

The warranty accrual activity for the periods noted consisted of the following:


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2021			2020			2021			2020
	(in thousands)
Warranty accrual at beginning of period	$	47,462		$	56,772		$	50,852		$	47,639
Accrual during the period		5,285			5,963			15,532			14,337
Cost of warranty services provided during the period		(9,826	)		(10,895	)		(21,178	)		(19,377	)
Changes in estimate for pre-existing warranties, including expirations during the period		(442	)		1,756			(2,727	)		10,997
Warranty accrual at end of period	$	42,479		$	53,596		$	42,479		$	53,596

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

(in thousands)

Warranty accrual at beginning of period

$
56,772

$
42,834

$
47,639

$
36,765

Accrual during the period

5,963

7,390

14,337

18,413

Cost of warranty services provided during the period

(10,895
)

36

(19,377
)

(2,409
)
Changes in estimate for pre-existing warranties,
including expirations during the period

1,756

(1,978
)

10,997

(4,487
)
Warranty accrual at end of period

$
53,596

$
48,282

$
53,596

$
48,282

Note 5. Long-Term Debt, Net of ~~Debt Issuance Costs and~~ Current Maturities

Long-term debt, net of ~~debt issuance costs and~~ current maturities, consisted of the following:

September 30,

December 31,

2020

2019

(in thousands)

Senior revolving loan—U.S.

$
185,215

$
112,414

Accounts receivable financing—EMEAI

—

3,805

Unsecured financing—EMEAI

34,743

—

Equipment financing—EMEAI

5,165

7,903

Equipment finance lease—U.S.

147

288

Equipment finance lease—EMEAI

4,488

5,732

Equipment finance lease—Mexico

8,975

11,919

Total debt - principal

238,733

142,061

Less: Debt issuance costs

(1,165
)

(672
)
Total debt, net of debt issuance costs

237,568

141,389

Less: Current maturities of long-term debt

(35,788
)

(13,501
)
Long-term debt, net of debt issuance costs and
current maturities

$
201,780

$
127,888

~~Senior Revolving Loan -~~ ~~U.S.:~~


	September 30,			December 31,
	2021			2020
	(in thousands)
Senior revolving loan—U.S.	$	181,154		$	171,154
Unsecured financing—EMEA		52,683			30,040
Equipment financing—EMEA		1,027			4,335
Secured and unsecured working capital—India		10,334			0
Unsecured term loan—India		8,109			0
Equipment finance lease—Mexico		6,927			8,038
Equipment finance lease—EMEA		2,459			4,119
Other equipment finance leases		145			232
Total debt—principal		262,838			217,918
Less: Debt issuance costs		(709	)		(1,051	)
Total debt, net of debt issuance costs		262,129			216,867
Less: Current maturities of long-term debt		(251,563	)		(32,551	)
Long-term debt, net of debt issuance costs and current maturities	$	10,566		$	184,316

As of September 30, 2021, we were not in compliance with our Total Net Leverage Ratio financial covenant (as defined in our Credit Agreement) and as a result the lender would have the right to request immediate payment of the senior revolving loan. Our liquidity and capital resources were adversely affected by certain events that occurred during the three months ended September 30, 2021. We experienced significant production delays that occurred at the Matamoros, Mexico manufacturing facility that we took over from Nordex in July 2021, as well as significant production delays in one of our Juarez, Mexico manufacturing facilities in connection with the ongoing transition to an innovative new blade for one of our customers. Although we expect that production will be stabilized in both of these manufacturing facilities by the end of the year, we expect that these transitions will continue to have an adverse impact on our liquidity for the remainder of the year. We also expect decreased demand for our wind blades from our customers during the remainder of 2021 and 2022. We believe this decrease in demand is due to the continued global renewable energy regulatory and policy uncertainty and raw material cost increases and constraints. We believe this decreased demand will also adversely impact our profitability and liquidity for the remainder of 2021 and 2022. Absent any other action or failure to close on item (i) discussed below, we will require additional liquidity to continue operations over the next 12 months.

In ~~February 2020,~~response to these conditions, we entered into ~~an Incremental Facility Agreement with the current lenders to our Credit~~(i) a $350 million Series A Preferred Stock Purchase Agreement and ~~an additional lender, pursuant to which~~(ii) executed a limited 30-day credit agreement waiver through December 8, 2021. Per the ~~aggregate principal amount~~terms of ~~our revolving credit facility under~~ the ~~Credit Agreement was~~Series A Preferred Stock Purchase

1615

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~(Unaudited)~~

~~increased from $150.0 million~~(Unaudited)

Agreement, a portion of the funds raised through the Series A Preferred Stock Purchase Agreement will be used to ~~$205.0 million. All borrowings and~~repay in full amounts outstanding under the Credit ~~Agreement are scheduled~~Agreement. We also may elect at our option to ~~mature in~~ require the purchaser to purchase an additional $~~April 2023~~50.0.

~~In June 2020, we entered into an amendment to our Credit Agreement which made certain adjustments to one~~ million of Series A Preferred Stock upon the financial covenants, added new covenants related to minimum liquidity and mandatory repayment triggers, provided for certain modifications to the affirmative and negative covenants and changed the interest rate during the Adjustment Period (as defined in the Credit Agreement) to a LIBOR floor of 0.75% plus a margin of 3.0% per annum. The interest rate following the end of the Adjustment Period would be equal to a LIBOR floor of 0.75% plus a margin ranging between 1.75% to 2.50% per annum. All other materialsame terms and conditions as the initial issuance of the ~~Credit Agreement remained~~Series A Preferred Stock during the ~~same.~~

~~Unsecured Financing - EMEAI:~~

Intwo-year period following the ~~fourth quarter of 2019,~~closing date. Accordingly, we ~~entered into~~have reclassified the balance outstanding under our senior revolving loan as a ~~credit agreement with a Turkish financial institution to provide up to 100.0 million Turkish Lira (approximately $12.8 million~~current liability as of September 30, ~~2020)~~2021. We believe our plans are probable of ~~unsecured financing. Interest accrues at~~occurring and sufficient to support ongoing operations for the foreseeable future. See Note 15, Subsequent Events, for a ~~fixed rate of 2.0% and is payable at the end~~further discussion of the ~~term when~~Series A Preferred Stock Purchase Agreement and the loan is repaid. The credit agreement does not have an expiration date, however the limits are reviewed in January of each year to establish available capacity. As of September 30, 2020, there was $3.5 million outstanding under this agreement. The amount outstanding was repaid in October 2020. NaN amounts were outstanding under this credit agreement as of December 31, 2019.limited waiver.

In the first quarter of 2020, we entered into a credit agreement, as amended, with a Turkish financial institution to provide up to $18.0 million of unsecured financing. Interest accrues at a fixed rate of 2.4% and is payable quarterly. The maturity date for amounts currently outstanding is March 2023. The credit agreement does not have an expiration date, however the limits are reviewed in December of each year to establish available capacity. As of September 30, 2020, there was $14.7 million outstanding under this credit agreement.

In the first quarter of 2020, we entered into a credit agreement with a Turkish financial institution to provide up to 5.0 million Euro (approximately $5.9 million as of September 30, 2020) of unsecured financing. Interest accrues at a fixed rate of 5.0% and is payable at the end of the term when the loan is repaid. The credit agreement does not have an expiration date, however the limits are reviewed in February of each year to establish available capacity. As of September 30, 2020, there were 0 amounts outstanding under this credit agreement.

In the second and third quarters of 2020, we amended an existing credit agreement with a Turkish financial institution to provide up to 31.0 million Euro (approximately $36.3 million as of September 30, 2020) of financing of which 11.0 million Euro (approximately $12.9 million as of September 30, 2020) is comprised of unsecured financing, letters of credit and other non-cash items and 20.0 million Euro (approximately $23.4 million as of September 30, 2020) related to an unsecured revolving credit facility. Interest on the 11.0 million Euro facility was determined based upon the term of the loan utilizing the one-month Euro Interbank Offered Rate (EURIBOR) plus 1.50% (1.50%) and was fully paid on the loan origination date. Interest on the 20.0 million Euro facility accrues at a fixed rate of 4.75% and is payable at the end of the term when the loan is repaid. The maturity date for amounts currently outstanding under the 11.0 million Euro facility is April 2021. The facilities do not have an expiration date, however the limits are reviewed in July of each year to establish available capacity. As of September 30, 2020, there was approximately 9.1 million Euro, or $10.7 million, outstanding under the 11.0 million Euro facility and 0ne outstanding under the 20.0 million Euro facility.

In the third quarter of 2020, we amended an existing credit agreement with a Turkish financial institution to provide up to $21.0 million of unsecured financing. Interest on the unsecured financing accrues at a fixed rate of 3.0% and is payable at the end of the term when the loan is repaid. The maturity date for amounts currently outstanding is February 2021. The unsecured financing agreement does not have an expiration date, however the limits are reviewed in September of each year to establish available capacity. As of September 30, 2020, there was $5.8 million outstanding under the credit agreement.

Note 6. Share-Based Compensation Plans

During the nine months ended September 30, ~~2020,~~2021, we issued to certain employees and non-employee directors an aggregate of ~~461,732~~168,993 timed-based restricted stock units (RSUs), ~~122,752~~58,396 performance-based restricted stock units (PSUs) that vest upon achievement of a cumulative, three-year Adjusted EBITDA target measured from January 1, ~~2020~~2021 through December 31, ~~2022,~~2023, and ~~198,826~~79,784 PSUs that vest upon achievement of certain stock price hurdles for the period of the grant date through December 31, ~~2022.~~2023. All of the time-based RSUs vest on the third anniversary date of the grant date. Each of the time-based and performance-based awards are subject to the recipient’s continued service with us, the terms and conditions of ~~the 2015 Plan~~our stock option and incentive plan and the applicable award agreement.

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~In addition, during the nine months ended September 30, 2020, we issued~~ ~~261,181~~ ~~stock options to certain employees and non-employee directors.~~

The share-based compensation expense recognized in the condensed consolidated statements of operations was as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
	(in thousands)
Cost of goods sold	$	678	$	479	$	2,010	$	1,115
General and administrative expenses		1,265		2,152		5,257		6,832
Total share-based compensation expense	$	1,943	$	2,631	$	7,267	$	7,947

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

(in thousands)

Cost of goods sold

$
479

$
(35
)

$
1,115

$
313

General and administrative expenses

2,152

1,717

6,832

4,291

Total share-based compensation expense

$
2,631

$
1,682

$
7,947

$
4,604

The share-based compensation expense recognized by award type was as follows:


	Three Months Ended				Nine Months Ended				Three Months Ended					Nine Months Ended
	September 30,				September 30,				September 30,					September 30,
	2020		2019		2020		2019		2021			2020		2021		2020
	(in thousands)								(in thousands)
RSUs	$	1,262	$	869	$	3,399	$	2,800	$	1,506		$	1,262	$	4,533	$	3,399
Stock options		700		225		2,952		955		466			700		1,657		2,952
PSUs		669		588		1,596		849		(29	)		669		1,077		1,596
Total share-based compensation expense	$	2,631	$	1,682	$	7,947	$	4,604	$	1,943		$	2,631	$	7,267	$	7,947

~~Included in total share-based compensation expense for~~During the ~~nine~~three months ended September 30, ~~2020 is $1.7~~2021, we derived a $0.7 million benefit related to the reduction of ~~compensation expense associated with~~ the ~~modification~~probability to zero of certain ~~employee and non-employee awards during the nine month period. The modifications primarily provided for the extension~~PSUs that vest upon achievement of ~~the post termination exercise period of outstanding stock options, resulting in~~ a ~~one-time charge in the nine months ended September 30, 2020.~~cumulative, three-year Adjusted EBITDA target.

Note 7. Leases

We have operating and finance leases for our manufacturing facilities, warehouses, offices, automobiles and certain of our machinery and equipment. Our leases have remaining lease terms of between one and 15 years, some of which may include options to extend the leases up to five ~~years.~~years.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The components of lease cost were as follows:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
	(in thousands)
Total operating lease cost	$	9,768	$	9,546	$	29,129	$	27,265

Finance lease cost
Amortization of assets under finance leases	$	870	$	1,529	$	2,676	$	4,489
Interest on finance leases		144		240		502		775
Total finance lease cost	$	1,014	$	1,769	$	3,178	$	5,264

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

(in thousands)

Total operating lease cost

$
9,546

$
7,893

$
27,265

$
23,830

Finance lease cost

Amortization of assets under finance leases

$
1,529

$
1,749

$
4,489

$
4,970

Interest on finance leases

240

323

775

1,119

Total finance lease cost

$
1,769

$
2,072

$
5,264

$
6,089

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Total lease assets and liabilities ~~as of September 30, 2020~~ were as follows:


	September 30,			December 31,
	2021			2020
	(in thousands)
Operating Leases
Operating lease right of use assets	$	146,794		$	158,827

Current operating lease liabilities	$	22,939		$	26,099
Noncurrent operating lease liabilities		149,742			155,925
Total operating lease liabilities	$	172,681		$	182,024

Finance Leases
Property, plant and equipment, gross	$	26,958		$	28,462
Less: accumulated depreciation		(14,065	)		(12,461	)
Total property, plant and equipment, net	$	12,893		$	16,001

Current maturities of long-term debt	$	6,296		$	6,018
Long-term debt, net of debt issuance costs and current maturities		3,235			6,371
Total finance lease liabilities	$	9,531		$	12,389

Operating

Finance

Leases

Leases

(in thousands)

Current operating lease liabilities

$
25,569

$
—

Current maturities of long-term debt

—

5,855

Noncurrent operating lease liabilities

165,551

—

Long-term debt, net of debt issuance costs and current maturities

—

7,755

Total lease liabilities

$
191,120

$
13,610

As of September 30, 2020, the cost and accumulated depreciation of property, plant and equipment that we are leasing under finance lease arrangements were $42.7 million and $20.4 million, respectively. As of December 31, 2019, the cost and accumulated depreciation of property, plant and equipment that we are leasing under finance lease arrangements were $45.0 million and $17.0 million, respectively.

Future minimum lease payments under noncancelable leases as of September 30, ~~2020~~2021 were as follows:


	Operating			Finance
	Leases			Leases
	(in thousands)
Year Ending December 31,
Remainder of 2021	$	9,576		$	1,407
2022		34,392			6,241
2023		31,995			1,353
2024		27,789			710
2025		27,199			379
Thereafter		101,634			6
Total future minimum lease payments		232,585			10,096
Less: interest		(59,904	)		(565	)
Total lease liabilities	$	172,681		$	9,531

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Operating

Finance

Leases

Leases

(in thousands)

Year Ending December 31,

Remainder of 2020

$
8,413

$
1,317

2021

35,295

6,544

2022

32,796

5,763

2023

31,010

865

2024

27,787

222

Thereafter

130,592

7

Total future minimum lease payments

265,893

14,718

Less: interest

(74,773
)

(1,108
)
Total lease liabilities

$
191,120

$
13,610

Supplemental cash flow information related to leases was as follows:


	Nine Months Ended
	September 30,
	2021		2020
	(in thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	27,116	$	22,308
Operating cash flows from finance leases		502		775
Financing cash flows from finance leases		4,249		4,592

Other information related to leases was as follows:

Nine Months Ended

September 30,

2020

2019

(in thousands)

Supplemental Cash Flow Information

Cash paid for amounts included in the measurement of lease
   liabilities:

  Operating cash flows from operating leases

$
22,308

$
22,977

  Operating cash flows from finance leases

775

1,119

  Financing cash flows from finance leases

4,592

7,621

Right of use assets obtained in exchange for new lease obligations:

  Operating leases

67,705

12,205

  Finance leases

131

5,122


	September 30,			December 31,
	2021			2020
Weighted-Average Remaining Lease Term (In Years):
Operating leases		7.1			7.7
Finance leases		2.0			2.2

Weighted-Average Discount Rate:
Operating leases		8.0	%		7.9	%
Finance leases		5.9	%		6.4	%

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

September 30,

December 31,

2020

2019

Weighted-Average Remaining Lease Term (In Years):

  Operating leases

7.9

7.6

  Finance leases

2.5

3.2

Weighted-Average Discount Rate:

  Operating leases

7.9
%

7.5
%
  Finance leases

6.4
%

6.4
%

As of September 30, ~~2020,~~2021, there were 0 material additional leases related to ~~new~~our manufacturing facilities, ~~that~~warehouses, offices, automobiles or our machinery and equipment which have not yet commenced.

Note 8. Financial Instruments

Interest Rate Swap

We use interest rate swap contracts to mitigate our exposure to interest rate fluctuations associated with our U.S. senior revolving credit agreement (the Credit Agreement) ~~that we entered into in April 2018.~~. We do not use such swap contracts for speculative or trading purposes.

~~To partially offset the variability~~As of ~~future interest payments on the Credit Agreement arising from changes in LIBOR, in April 2018, we entered into an~~September 30, 2021, 0 interest rate ~~swap agreement with a financial institution~~swaps originally designated for ~~a notional amount of $75.0 million with an expiration date of April 2023. This~~hedge accounting were de-designated or terminated. No ineffectiveness on our interest rate ~~swap effectively hedges $75.0 million~~swaps was recognized as of September 30, 2021, and none is anticipated over the remaining term of the future variable rate LIBOR interest expense converting it to a fixed rate interest expense. The derivative instrument qualified for accounting as a cash flow hedge in accordance with FASB Accounting Standard Codification (ASC) Topic 815, agreement.~~Derivatives and Hedging,~~ ~~and we designated it as such.~~

Foreign Exchange Forward Contracts

We use foreign exchange forward contracts to mitigate our exposure to fluctuations in exchange rates between the functional currencies of our subsidiaries and the other currencies in which they transact. ~~In September 2019, we entered into the first of these foreign exchange forward contracts.~~ We do not use such forward contracts for speculative or trading purposes.

~~We expect certain~~Mexican Peso

All of our subsidiaries to have future cash flows that will be denominated in currencies other than the subsidiaries’ functional currencies. Changes in the exchange rates between the functional currencies of our subsidiaries and the other currencies in which they transact will cause fluctuations in the cash flows we expect to receive or pay when these cash flows are realized or settled. Accordingly, we enter intoremaining outstanding foreign exchange forward contracts ~~to hedge a portion of these forecasted cash flows.~~(excluding those with call options) expired during the three months ended March 31, 2021. As of September 30, 2020, these foreign exchange forward contracts hedge our forecasted cash flows for periods up to six months. These foreign exchange forward contracts qualified for accounting as cash flow hedges in accordance with ASC Topic 815, and we designated them as such.

All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. For a detailed discussion of the fair value hierarchy, refer to the discussion in Note 1, ~~Summary of Operations and Significant Accounting Policies – Fair Value of Financial Instruments, to the Notes to Consolidated Financial Statements within our Annual Report on Form 10-K.~~

~~As of September 30, 2020 and~~ December 31, ~~2019,~~2020, the notional values associated with our foreign exchange forward contracts qualifying as cash flow hedges were ~~0.8~~approximately 0.3 billion Mexican Pesos (approximately ~~$32.2~~$14.0 million).

With regards to our foreign exchange call option contracts, for the three and ~~1.1 billion Mexican Pesos (approximately $54.8 million), respectively.~~

~~The fair values~~nine months ended September 30, 2021, $0.8 million and ~~location~~$2.2 million, respectively, of ~~financial instruments in our condensed consolidated balance sheets were as follows:~~

Condensed Consolidated

September 30,

December 31,

Financial Instrument

Balance Sheet Line Item

2020

2019

(in thousands)

Interest rate swap

Other noncurrent liabilities

4,882

2,723

Foreign exchange forward contracts

Other current assets

1,696

820

Foreign exchange forward contracts

Accounts payable and accrued
expenses

—

124

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~For cash flow hedges, the gain or loss is reported as a component~~premium amortization was recorded through cost of ~~accumulated other comprehensive loss in~~sales within our condensed consolidated statements of changes in stockholders’ equity and reclassified into earnings in our condensed consolidated statements of operations in the same period or periods during which the hedged transaction affects earnings.operations. The net income (loss) recognized in accumulated other comprehensive loss in our condensed consolidated statements of changes in stockholders’ equity for our foreign exchange ~~forward~~call option contracts is expected to be recognized in ~~Cost~~cost of ~~Sales~~sales in our condensed consolidated statements of operations during the next six months. ~~The gain or loss on~~

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

As of September 30, 2021 and December 31, 2020, the notional values associated with our ~~interest rate swap is~~foreign exchange call option contracts qualifying as cash flow hedges were approximately 1.0 billion Mexican Pesos (approximately $48.5 million) and approximately 0.4 billion Mexican Pesos (approximately $17.3 million), respectively.

Chinese Renminbi

With regards to our foreign exchange forward contracts, for which hedge accounting does not apply, for the three and nine months ended September 30, 2021, $0.6 million and $1.2 million, respectively, in gains were recorded ~~in accumulated other comprehensive loss and subsequently reclassified into Interest Expense in~~through foreign currency income (loss) within our condensed consolidated statements of ~~operations in~~operations.

India Rupee

With regards to our foreign exchange forward contracts and our foreign exchange call option contracts, for which hedge accounting does not apply, for the ~~period in which the hedged transaction affects earnings. As of~~three and nine months ended September 30, ~~2020, 0 interest rate swaps originally designated~~2021, $1.3 million and $2.5 million, respectively, in gains were recorded through foreign currency income (loss) within our condensed consolidated statements of operations. Additionally, with regards to our foreign exchange call option contracts, for ~~hedge accounting were de-designated or terminated. No ineffectiveness on our interest rate swaps was recognized as of~~the three and nine months ended September 30, ~~2020,~~2021, $0.4 million and ~~none is anticipated over the term~~$0.7 million, respectively, of ~~the agreement.~~premium amortization was recorded as losses through foreign currency income (loss) within our condensed consolidated statements of operations.

The fair values and location of our financial instruments in our condensed consolidated balance sheets were as follows:


	Condensed Consolidated	September 30,		December 31,
Financial Instrument	Balance Sheet Line Item	2021		2020
		(in thousands)
Foreign exchange forward contracts	Other current assets	$	2,028	$	5,832
Foreign exchange forward contracts	Accounts payable and accrued expenses		1,184		2,096
Interest rate swap	Other noncurrent liabilities		2,928		4,414

The following table presents the pretax amounts reclassified from accumulated other comprehensive loss into our condensed consolidated statements of operations:


Accumulated	Condensed Consolidated	Three Months Ended				Nine Months Ended
Other Comprehensive	Statement of Operations	September 30,				September 30,
Loss Component	Line Item	2021		2020		2021			2020
		(in thousands)
Foreign exchange forward contracts	Cost of sales	$	0	$	1,546	$	(3,037	)	$	4,062

Condensed

Three Months Ended

Nine Months Ended

Comprehensive Income

Consolidated Statement

September 30,

September 30,

(Loss) Component

of Operations Line Item

2020

2019

2020

2019

(in thousands)

Foreign exchange forward
contracts

Cost of sales

$
1,546

$
—

$
4,062

$
—

Note 9. Income Taxes

~~Income taxes~~

For the three months ended September 30, 2021, our income tax provision increased to $8.2 million as compared to a benefit of $32.3 million in the comparative prior year period, and for the ~~three and~~ nine months ended September 30, ~~2020~~2021, our income tax provision increased to $30.0 million as compared to a provision of $1.9 million in the comparative prior year period. These income tax increases were ~~lower than for the corresponding periods ended September 30, 2019~~ primarily due to the ~~impact of a~~ change in the ~~forecasted annual effective~~mix of earnings of foreign jurisdictions and U.S. tax ~~rates and~~on foreign earnings in the ~~earnings mix by jurisdiction~~current year periods. In addition, the increase in ~~2020~~the nine months ended September 30, 2021 as compared to ~~2019. The forecasted effective~~the same period in 2020 was due to the recording of a full U.S. valuation allowance and an increase in our uncertain tax ~~rate for~~positions in the current year differs from the U.S. statutory income tax rate primarily due to earnings in foreign jurisdictions with income tax rates that exceed the U.S. statutory income tax rate, losses incurred by an entity in a tax-free zone, and the establishment of a full valuation allowance on U.S. deferred items. period.

The Internal Revenue Service (IRS) issued final regulations in July 2020 to clarify Global Intangible Low Tax Income (GILTI) under the Tax Cuts and Jobs Act allowing us to make an annual election to exclude GILTI of our foreign subsidiaries with an effective tax rate greater than 90% of the U.S. corporate rate. The impact for this change in legislation was offset by the establishment of a full valuation allowance in the U.S. during the quarter.

No ~~additional~~ changes in tax law occurred during the ~~quarter~~nine months ended September 30, 2021, which ~~have~~had a material impact on our income tax provision.

We do not record a deferred tax liability related to unremitted foreign earnings as we maintain our assertion to indefinitely reinvest our unremitted foreign earnings.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 10. Net Income (Loss) Per Common Share ~~Calculation~~

~~Basic net income (loss) per common share is computed by dividing~~The following table sets forth the ~~net income (loss) by the weighted-average number~~computation of common shares outstanding during a period. Diluted net income per common share is computed by giving effect to all potentially dilutive securities, unless there is a net loss for the period and/or performance-based awards which are not included until performance conditions are met. In computing diluted net income per common share, we use the treasury stock method. The table below reflects the

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~calculation of the weighted-average number of common shares outstanding, using the treasury stock method, used in computing~~ basic and diluted net income (loss) per common share:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,				Three Months Ended					Nine Months Ended
	2020		2019		2020		2019		September 30,					September 30,
	(in thousands)								2021			2020		2021			2020
									(in thousands, except per share data)
Numerator:
Net income (loss)									$	(30,677	)	$	42,382	$	(72,271	)	$	(24,211	)

Denominator:
Basic weighted-average shares outstanding		35,546		35,131		35,354		35,024		37,052			35,546		36,846			35,354
Effect of dilutive awards		1,877		0		0		0		0			1,877		0			0
Diluted weighted-average shares outstanding		37,423		35,131		35,354		35,024		37,052			37,423		36,846			35,354

Basic net income (loss) per common share									$	(0.83	)	$	1.19	$	(1.96	)	$	(0.68	)
Diluted net income (loss) per common share									$	(0.83	)	$	1.13	$	(1.96	)	$	(0.68	)

Potentially dilutive shares excluded from the calculation due to net losses in the period										1,312			0		1,693			1,399
Anti dilutive share-based compensation awards excluded from the calculation										13			1		0			33
Performance-based restricted stock units excluded from the calculation because the performance conditions had not been met										265			192		265			192

Since there were net losses for the nine months ended September 30, 2020, approximately 1,400,000 potentially dilutive shares were excluded from the calculation. Additionally, since there were net losses for the three and nine months ended September 30, 2019, approximately 980,000 and 1,304,000 potentially dilutive shares were excluded from the calculation. In addition, the table below summarizes the approximate number of share-based compensation awards which were excluded from the computation of net income (loss) per common share because their effect would be anti-dilutive:

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Anti-dilutive shares

1,000

27,000

33,000

14,000

Note 11. Stockholders’ Equity

Accumulated Other Comprehensive Loss

The following tables presents the changes in accumulated other comprehensive loss (AOCL) by component:

	Nine Months Ended September 30, 2020
													Nine Months Ended September 30, 2021
	Foreign						Foreign						Foreign						Foreign
	currency						exchange						currency						exchange
	translation			Interest rate			forward			Total			translation			Interest rate			forward			Total
	adjustments			swap			contracts			AOCL			adjustments			swap			contracts			AOCL
	(in thousands)												(in thousands)
Balance at December 31, 2019	$	(22,012	)	$	(2,145	)	$	545		$	(23,612	)
Balance at December 31, 2020													$	(30,111	)	$	(3,443	)	$	564		$	(32,990	)
Other comprehensive income (loss) before reclassifications		(9,223	)		(2,550	)		(6,936	)		(18,709	)		(5,291	)		597			(2,281	)		(6,975	)
Amounts reclassified from AOCL		—			—			(222	)		(222	)		0			0			(2,002	)		(2,002	)
Net tax effect		—			535			1,503			2,038			0			(139	)		790			651
Net current period other comprehensive income (loss)		(9,223	)		(2,015	)		(5,655	)		(16,893	)		(5,291	)		458			(3,493	)		(8,326	)
Balance at March 31, 2020		(31,235	)		(4,160	)		(5,110	)		(40,505	)
Balance at March 31, 2021														(35,402	)		(2,985	)		(2,929	)		(41,316	)
Other comprehensive income (loss) before reclassifications		(2,290	)		—			1,750			(540	)		(4	)		452			259			707
Amounts reclassified from AOCL		—			—			2,738			2,738			0			0			(1,035	)		(1,035	)
Net tax effect		—			—			(938	)		(938	)		0			(105	)		190			85
Net current period other comprehensive income (loss)		(2,290	)		—			3,550			1,260			(4	)		347			(586	)		(243	)
Balance at June 30, 2020		(33,525	)		(4,160	)		(1,560	)		(39,245	)
Balance at June 30, 2021														(35,406	)		(2,638	)		(3,515	)		(41,559	)
Other comprehensive income (loss) before reclassifications		(1,662	)		391			2,124			853			(889	)		437			(771	)		(1,223	)
Amounts reclassified from AOCL		—			—			1,546			1,546			0			0			0			0
Net tax effect		—			(535	)		(565	)		(1,100	)		0			244			(638	)		(394	)
Net current period other comprehensive income (loss)		(1,662	)		(144	)		3,105			1,299			(889	)		681			(1,409	)		(1,617	)
Balance at September 30, 2020	$	(35,187	)	$	(4,304	)	$	1,545		$	(37,946	)
Balance at September 30, 2021													$	(36,295	)	$	(1,957	)	$	(4,924	)	$	(43,176	)

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Nine Months Ended September 30, 2020
	Foreign						Foreign
	currency						exchange
	translation			Interest rate			forward			Total
	adjustments			swap			contracts			AOCL
	(in thousands)
Balance at December 31, 2019	$	(22,012	)	$	(2,145	)	$	545		$	(23,612	)
Other comprehensive income (loss) before reclassifications		(9,223	)		(2,550	)		(6,936	)		(18,709	)
Amounts reclassified from AOCL		0			0			(222	)		(222	)
Net tax effect		0			535			1,503			2,038
Net current period other comprehensive income (loss)		(9,223	)		(2,015	)		(5,655	)		(16,893	)
Balance at March 31, 2020		(31,235	)		(4,160	)		(5,110	)		(40,505	)
Other comprehensive income (loss) before reclassifications		(2,290	)		0			1,750			(540	)
Amounts reclassified from AOCL		0			0			2,738			2,738
Net tax effect		0			0			(938	)		(938	)
Net current period other comprehensive income (loss)		(2,290	)		0			3,550			1,260
Balance at June 30, 2020		(33,525	)		(4,160	)		(1,560	)		(39,245	)
Other comprehensive income (loss) before reclassifications		(1,662	)		391			2,124			853
Amounts reclassified from AOCL		0			0			1,546			1,546
Net tax effect		0			(535	)		(565	)		(1,100	)
Net current period other comprehensive income (loss)		(1,662	)		(144	)		3,105			1,299
Balance at September 30, 2020	$	(35,187	)	$	(4,304	)	$	1,545		$	(37,946	)

Nine Months Ended September 30, 2019

Foreign

Foreign

currency

exchange

translation

Interest rate

forward

Total

adjustments

swap

contracts

AOCL

(in thousands)

Balance at December 31, 2018

$
(14,986
)

$
594

$
—

$
(14,392
)
Other comprehensive income (loss) before reclassifications

1,333

(2,291
)

—

(958
)
Amounts reclassified from AOCL

—

—

—

—

Net tax effect

—

481

—

481

   Net current period other comprehensive income (loss)

1,333

(1,810
)

—

(477
)
Balance at March 31, 2019

(13,653
)

(1,216
)

—

(14,869
)
Other comprehensive income (loss) before reclassifications

(4,203
)

(1,355
)

—

(5,558
)
Amounts reclassified from AOCL

—

—

—

—

Net tax effect

—

284

—

284

   Net current period other comprehensive income (loss)

(4,203
)

(1,071
)

—

(5,274
)
Balance at June 30, 2019

(17,856
)

(2,287
)

—

(20,143
)
Other comprehensive income (loss) before reclassifications

(895
)

(395
)

(561
)

(1,851
)
Amounts reclassified from AOCL

—

—

—

—

Net tax effect

—

84

118

202

   Net current period other comprehensive income (loss)

(895
)

(311
)

(443
)

(1,649
)
Balance at September 30, 2019

$
(18,751
)

$
(2,598
)

$
(443
)

$
(21,792
)

Note 12. Commitments and Contingencies

Legal Proceedings

From time to time, we are party to various lawsuits, claims, and other legal proceedings that arise in the ordinary course of business, some of which ~~are~~may not be covered by insurance. Upon resolution of any pending legal matters, we may incur charges in excess of presently established ~~reserves or our insurance policy limits.~~reserves. Our management does not believe that any such charges would, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations or cash flows.

In January 2021, we received a complaint that was filed by the administrator for the Senvion GmbH (Senvion) insolvency estate in German insolvency court. The complaint asserts voidance against us in the aggregate amount of $13.3 million. The alleged voidance claims relate to payments that Senvion made to us for wind blades that we produced prior to Senvion filing for insolvency protection. We filed a response to these alleged voidance claims in August 2021 and we believe we have meritorious defenses to the alleged voidance claims. Due to the early stage of this claim, we have determined that the ultimate outcome cannot be estimated at this time.

Note 13. Concentration of Customers

~~Revenues~~Net sales from certain customers (in thousands) in excess of 10 percent of our total consolidated ~~revenues~~net sales are as follows:


	Three Months Ended										Nine Months Ended										Three Months Ended										Nine Months Ended
	September 30,										September 30,										September 30,										September 30,
	2020					2019					2020					2019					2021					2020					2021					2020
Customer	Revenues		% of Total			Revenues		% of Total			Revenues		% of Total			Revenues		% of Total			Net sales		% of Total			Net sales		% of Total			Net sales		% of Total			Net sales		% of Total
Vestas	$	240,710		50.8	%	$	176,018		45.9	%	$	591,548		49.1	%	$	446,733		44.0	%	$	176,107		36.7	%	$	240,710		50.8	%	$	554,112		41.3	%	$	591,548		49.1	%
GE		124,523		26.3	%		96,312		25.1	%		295,831		24.6	%		272,859		26.9	%		122,347		25.5	%		124,523		26.3	%		333,136		24.8	%		295,831		24.6	%
Nordex		53,182		11.2	%		61,514		16.0	%		168,697		14.0	%		170,044		16.8	%		123,373		25.7	%		53,182		11.2	%		281,421		21.0	%		168,697		14.0	%

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Trade accounts receivable from certain customers in excess of 10 percent of our total consolidated trade accounts receivable are as follows:


	September 30,			December 31,			September 30,			December 31,
	2020			2019			2021			2020
Customer	% of Total			% of Total			% of Total			% of Total
Nordex								43.5	%		40.8	%
Vestas		41.3	%		41.9	%		27.7	%		35.0	%
Nordex		32.4	%		31.3	%
Enercon								10.7	%		8.3	%

~~TPI COMPOSITES, INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Note 14. Segment Reporting

Our operating segments are defined geographically into 45 geographic operating segments—(1) the United States (U.S.), (2) Asia, (3) Mexico, (4) EMEA and ~~(4) Europe, the Middle East, Africa and India (EMEAI).~~(5) India. For a detailed discussion of our operating segments, refer to the discussion in Note 1, 19, ~~Summary of Operations and Significant Accounting Policies – Basis of Presentation~~Segment Reporting, to the Notes to Consolidated Financial Statements within our Annual Report on Form 10-K.

~~Financial results are aggregated into these 4 reportable segments based on quantitative thresholds.~~ All of our segments operate in their local currency ~~however~~except for the Mexico and Asia segments, which both include a ~~portion of~~U.S. parent company, and India and Switzerland, which operate in the ~~revenue attributable to our Asia and Mexico segments is derived in~~ U.S. ~~dollars because certain of our domestic subsidiaries are the contracting parties to the associated customer supply agreements.~~dollar.

The following tables set forth certain information regarding each of our segments:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,						Three Months Ended						Nine Months Ended
	2020			2019			2020			2019			September 30,						September 30,
	(in thousands)												2021			2020			2021			2020
Revenues by segment:
													(in thousands)
Net sales by segment:
U.S.	$	46,799		$	40,643		$	136,309		$	122,129		$	47,702		$	46,799		$	153,749		$	136,309
Asia		163,458			108,114			400,513			261,531			51,869			163,458			219,903			400,513
Mexico		161,563			117,690			363,233			297,717			200,332			161,563			461,961			363,233
EMEAI		102,293			117,389			304,511			333,010
Total revenues	$	474,113		$	383,836		$	1,204,566		$	1,014,387
Revenues by geographic location ⁽¹⁾:
U.S.	$	46,799		$	40,643		$	136,309		$	122,129
EMEA														129,444			83,640			347,160			260,138
India														50,252			18,653			160,347			44,373
Total net sales													$	479,599		$	474,113		$	1,343,120		$	1,204,566

Net sales by geographic location (1):
United States													$	47,702		$	46,799		$	153,749		$	136,309
China		163,458			108,114			400,513			261,531			51,869			163,458			219,903			400,513
Mexico		161,563			117,690			363,233			297,717			200,332			161,563			461,961			363,233
Turkey and India		102,293			117,389			304,511			333,010
Total revenues	$	474,113		$	383,836		$	1,204,566		$	1,014,387
Turkey														129,444			83,640			347,160			260,138
India														50,252			18,653			160,347			44,373
Total net sales													$	479,599		$	474,113		$	1,343,120		$	1,204,566

Income (loss) from operations:
U.S. ⁽²⁾	$	(6,360	)	$	(17,510	)	$	(33,991	)	$	(54,235	)	$	(24,598	)	$	(6,360	)	$	(36,070	)	$	(33,991	)
Asia		25,779			13,448			49,343			4,779			(3,607	)		25,779			7,207			49,343
Mexico		11,986			(4,954	)		(1,106	)		(1,258	)		(3,802	)		11,986			(33,082	)		(1,106	)
EMEAI		(2,400	)		21,134			(13,900	)		55,673
Total income from operations	$	29,005		$	12,118		$	346		$	4,959
EMEA														9,423			1,795			29,993			3,314
India														(1,403	)		(4,195	)		2,725			(17,214	)
Total loss from operations													$	(23,987	)	$	29,005		$	(29,227	)	$	346

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	September 30,		December 31,
	2021		2020
	(in thousands)
Property, plant and equipment, net:
U.S.	$	27,258	$	31,811
Asia (China)		37,555		46,075
Mexico		75,573		78,813
EMEA (Turkey)		20,776		28,312
India		31,164		23,990
Total property, plant and equipment, net	$	192,326	$	209,001

(1) Net sales are attributable to countries based on the location where the product is manufactured or the services are performed.

(2) The losses from operations in our U.S. segment includes corporate general and administrative costs of $8.2 million and $9.3 million for the three months ended September 30, 2021 and 2020, respectively, and $23.8 million and $25.6 million for the nine months ended September 30, 2021 and 2020, respectively.

September 30,

December 31,

2020

2019

(in thousands)

Property, plant and equipment, net:

U.S.

$
32,088

$
36,410

Asia (China)

48,276

50,603

Mexico

80,601

81,654

EMEAI (Turkey and India)

49,059

36,340

Total property, plant and equipment, net

$
210,024

$
205,007

Note 15. Subsequent Events

Credit Agreement Limited Waiver

On November 8, 2021 (the Waiver Effective Date), we executed a limited waiver in connection with our Credit Agreement, dated as of April 6, 2018 (as amended, restated, supplemented or otherwise modified from time to time), by and among ourselves, JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the Administrative Agent), and the lenders from time to time party thereto, with respect to our failure to comply with the Total Net Leverage Ratio (as defined in the Credit Agreement) financial covenant as of September 30, 2021. Pursuant to the terms of the limited waiver, the lenders have agreed to temporarily waive our compliance with this financial covenant from the Waiver Effective Date through December 8, 2021 (the Waiver Period). We also must maintain domestic U.S. cash of at least $20.0 million and global available liquidity (as defined in the Credit Agreement) of at least $50.0 million as of the close of business on each Friday commencing as of November 5, 2021 through the maturity date of the Credit Agreement. From and after the Waiver Effective Date, we may not allow any of our subsidiaries that are not loan parties to the Credit Agreement to incur any additional indebtedness and we may not make any investment in any of our subsidiaries that are not loan parties to the Credit Agreement in an aggregate amount greater than $5.0 million. We had $68.3 million of domestic U.S cash and $132.9 million of global available liquidity as of October 29, 2021.

Series A Preferred Stock Purchase Agreement

On November 8, 2021, we entered into a Series A Preferred Stock Purchase Agreement (the Purchase Agreement) with Oaktree Power Opportunities Fund V (Delaware) Holdings, L.P., OPPS TPIC Holdings, LLC, and Oaktree Phoenix Investment Fund L.P. (collectively, the Purchasers). Pursuant to the Purchase Agreement, we agreed to issue and sell to the Purchasers an aggregate of 350,000 shares of our newly designated Series A Preferred Stock, par value $0.01 per share (the Series A Preferred Stock), for an aggregate purchase price of $350.0 million, with the Series A Preferred Stock having the powers, designations, preferences, and other rights set forth in the Certificate of Designations (as defined below). The issuance and sale of the Series A Preferred Stock will occur on or after the date upon which customary closing conditions set forth in the Purchase Agreement have been satisfied (the Closing Date), which we expect will occur prior to December 8, 2021. We also may elect at our option to require Oaktree to purchase an additional $50.0 million of Series A Preferred Stock upon the same terms and conditions as the initial issuance of the Series A Preferred Stock during the two-year period following the Closing Date. We intend to use the net proceeds from the issuance and sale of the Series A Preferred Stock on the Closing Date to repay all outstanding indebtedness under our Credit Agreement, which is a condition to closing, and the remainder for general corporate purposes.

Warrant

On the Closing Date, we will also issue the Purchasers a warrant to purchase an aggregate of 4,666,667 shares of our Common Stock, at an exercise price of $0.01 per share (the “Warrant”). The Warrant will have a five-year term and may be exercised at any time

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

during that period. The number of shares issuable upon exercise of the Warrant is subject to customary adjustments upon the occurrence of certain events such as stock splits, reclassifications, combinations, dividends, distributions, mergers and other similar events.

Certificate of Designations

The Series A Preferred Stock will have the powers, designations, preferences, and other rights as set forth in a Certificate of Designations of the Series A Preferred Stock that will be filed by us with the Secretary of State of the State of Delaware on or before the Closing Date (the Certificate of Designations).

Voting and Consent Rights

The Series A Preferred Stock will not have any voting or rights to convert such preferred shares into shares of Common Stock (the Common Stock). We must obtain the prior written consent of holders of a majority of the outstanding shares of Series A Preferred Stock for, among other things: (i) amending our organizational documents to the extent such amendment has an adverse effect on the holders of our Series A Preferred Stock, (ii) effecting any change of control, liquidation event or merger or consolidation of us unless the entirety of the applicable Series A Redemption Price (as defined below) has been paid with respect to all issued and outstanding Series A Preferred Stock, (iii) increasing or decreasing the number of authorized shares of Series A Preferred Stock; (iv) making certain material acquisitions or dispositions or entering into joint ventures or similar transactions, (v) incurring indebtedness except for indebtedness incurred under our existing loan facilities and agreements so long as the total amount of such indebtedness does not exceed $100.0 million as of the Closing Date through December 31, 2021 and $80.0 million thereafter, (vi) committing to any capital expenditures to construct or acquire new manufacturing facilities, subject to limited exceptions; and (vii) certain other specified actions.

Dividends

The dividend rate with respect to the Series A Preferred Stock is 11.0% per annum and will compound on a quarterly basis. The dividend rate will increase by 2.0% per annum: (i) on the fifth anniversary date of the Closing Date and on each anniversary thereafter, (ii) to the extent that we fail to pay any dividend that is required to be paid in cash, if we are in material breach of its covenants under the Purchase Agreement, the Certificate of Designations or Investor Rights Agreement, or if we experience a bankruptcy or insolvency event, or if certain other Events of Non-compliance (as defined in the Certificate of Designations) occur; (iv) in the event we fail to maintain a specified fixed charge dividend coverage ratio, and (v) in respect of any Series A Preferred Stock issued as curative equity in accordance with the Investor Rights Agreement (each, an “Incremental Dividend”); provided that in no event shall the dividend rate exceed 20.0%. On or prior to the second anniversary of the Closing Date, we may pay dividends on the Series A Preferred Stock either in cash or “in kind”, through accrual to the liquidation preference of the Series A Preferred Stock or a combination thereof.Following the second anniversary of the Closing Date, dividends shall be payable only in cash.Incremental Dividends must be made in cash.

Ranking and Liquidation Preference

The Series A Preferred Stock ranks senior to the Common Stock with respect to dividend rights and rights upon the voluntary or involuntary liquidation, dissolution or winding up of our affairs (a Liquidation). Upon a Liquidation, each share of our Series A Preferred Stock would be entitled to the applicable Series A Redemption Price. The initial liquidation preference of the Series A Preferred Stock shall be equal to $1,000 plus any dividends that have accrued as the date of determination (the Series A Liquidation Preference).

Redemption Rights and Series A Redemption Price

We will have the right to redeem all or any portion of the Series A Preferred Stock at any time by paying the applicable Series A Redemption Price; provided, however, that no optional redemption will be permitted that would result in less than 10% of the shares of Series A Preferred Stock that are issued on the Closing Date remaining outstanding following such redemption unless all remaining shares of Series A Preferred Stock are redeemed.

TPI COMPOSITES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Each holder of Series A Preferred Stock will have the option to require us to redeem any portion of the Series A Preferred Stock at any time after the fifth anniversary of the Closing Date or an Event of Noncompliance occurs. We will be required to redeem all of the outstanding shares of Series A Preferred Stock automatically upon the occurrence of a change of control, Liquidation or insolvency event.

The following table sets forth the procedure for calculating the Series A Redemption Price at which the Series A Preferred Stock may be redeemed under the Certificate of Designations:


~~(1)~~Timing of Redemption	~~Revenues are attributable to countries based on the location where the product is manufactured or the services are performed.~~Series A Redemption Price

~~(2)~~Before the third anniversary of the Closing Date	~~The losses from operations in our U.S. segment includes corporate general~~Make-Whole Amount
From the First Optional Call Date until the first anniversary of the First Optional Call Date…………	102% of the Series A Liquidation Preference
From and ~~administrative costs~~after the first anniversary of ~~$9.3 million and $10.6 million for~~ the ~~three months ended September 30, 2020 and 2019, respectively, and $25.6 million and $27.8 million for~~First Optional Call Date………	101% of the ~~nine months ended September 30, 2020 and 2019, respectively.~~Series A Liquidation Preference

The “Make-Whole Amount” means, with respect to any redemption of any share of the Series A Preferred Stock prior to the third anniversary of the Closing Date (the First Optional Call Date) is defined in the Certificate of Designations as an amount equal to the present value (calculated as provided below) as of the redemption date of the sum of (A) the remaining dividends that would accrue on such shares being redeemed from the day immediately following the redemption date to the First Optional Call Date plus (B) 102% of the Liquidation Preference of such shares being redeemed on the redemption date assuming that, for purposes of calculating clauses (A) and (B), such shares were to remain outstanding through the First Optional Call Date, and with the present value of such sum being computed using an annual discount rate (applied quarterly) equal to the rate on U.S. Treasury notes with maturity closest to the applicable redemption date plus 50 basis points.

Minimum Cash Balance

We are also required to maintain a minimum cash balance of $50.0 million, which will be measured on a monthly basis, so long as the Series A Preferred Stock remains outstanding.

Investor Rights Agreement

As a condition to the closing of the transactions contemplated by the Purchase Agreement, In connection with the Purchase Agreement, we and the Purchasers will enter into an Investor Rights Agreement (the Investor Rights Agreement) pursuant to which, among other things, we will grant the Purchasers certain customary registration rights with respect to the shares of Common Stock underlying the Warrants and certain other securities that may be issued to the Purchasers in respect of the Warrant. Pursuant to the Investors Rights Agreement, the Purchasers will be entitled to designate one representative (the Series A Director) to be appointed to our board of directors (the Board) or to appoint one non-voting observer to the Board, in each case so long as 33% of the Series A Preferred Stock issued on the Closing Date remains outstanding.. The Investor Rights Agreement further contains a number of other customary covenants and agreements, including certain standstill provisions, preemptive rights, rights of first refusal with respect to future debt financing transactions, and information rights.

The Investor Rights Agreements provides that the Purchasers will be restricted from transferring the Series A Preferred Stock to parties unaffiliated with the Purchasers without our prior written consent, which consent shall not be unreasonably withheld by us.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements and the related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q (Form 10-Q). Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those described in or implied by these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Form 10-Q or in our previously filed Annual Report on Form 10-K, particularly those under “Risk Factors.”

OVERVIEW

Our Company

We are the only independent manufacturer of composite wind blades for the wind energy market with a global manufacturing footprint. We deliver high-quality, cost-effective composite solutions through long term relationships with leading original equipment manufacturers (OEM) in the wind and transportation markets. We also provide field service inspection and repair services to our OEM customers and wind farm owners and operators, and supply high strength, lightweight and durable composite products to the transportation market. We are headquartered in Scottsdale, Arizona and operate factories throughout the U.S., China, Mexico, Turkey, and India. We operate additional engineering development centers in Denmark and Germany.

Our business operations are defined geographically into ~~four~~five geographic operating segments—(1) the United States (U.S.), (2) Asia, (3) Mexico, ~~and~~ (4) Europe, the Middle East and Africa (EMEA) and ~~India (EMEAI).~~(5) India. See Note 14, Segment Reporting, to our condensed consolidated financial statements for more details about our operating segments.

KEY TRENDS AND RECENT DEVELOPMENTS AFFECTING OUR BUSINESS

~~The COVID-19 pandemic adversely impacted our operations and~~Our results of operations for the three months ended September 30, 2021 were adversely affected by significant production delays that occurred at the Matamoros, Mexico manufacturing facility that we took over from Nordex in July 2021, as well as significant production delays in one of our Juarez, Mexico manufacturing facilities in connection with the ongoing transition to an innovative new blade for one of our customers. We expect that production will be stabilized in both of these manufacturing facilities by the end of the year.

Our results of operations for the three and nine months ended September 30, 2021 were adversely impacted by continued supply chain challenges, raw material shortages and increased logistics costs. During 2021, there have been both significant price increases and supply constraints with respect to resin and carbon fiber, which are key raw materials that we use to manufacture our products, as well as increases in logistics costs to obtain raw materials. The resin price increases and supply constraints are due to a multitude of factors, including the extreme cold weather in Texas in February 2021, fires at resin manufacturing facilities in China and unplanned maintenance outages at resin manufacturing facilities in Europe. Carbon fiber prices have increased primarily due to the cost of raw material inputs as well as increased global demand for carbon fiber across multiple industries. These raw material price and logistics cost increases adversely affected our results of operations by approximately $20 million and $24 million for the three and nine months ended September 30, 2021, respectively. We expect that the price of resin and carbon fiber will remain at elevated levels for the remainder of 2021 and into 2022. Approximately 55% of the resin and resin systems we use are purchased under contracts either controlled or borne by two of our customers and therefore these customers receive/bear 100% of any decrease or increase in resin prices. With respect to our other customer supply agreements, our customers typically receive/bear 70% of any raw material price decreases or increases. After taking into account our contractual share of any price increases for resin and carbon fiber, we estimate that the impact of these raw materials price increases, together with increased logistics costs, will adversely impact our results of operations by approximately $30 million for 2021. If the supply of resin feedstocks and carbon fiber continue to be constrained for an extended period of time, such shortages could impact our ability to meet our customers’ forecasted demand for our products for the remainder of 2021and into 2022 and have a further material adverse impact on our results of operations for the remainder of 2021 and 2022.

Our manufacturing facility in Yangzhou, China was shut down for approximately three weeks during the three months ended September 30, 2021 due to an outbreak of positive COVID-19 cases in Yangzhou City, which had an adverse impact on our results of operations for the three months ended September 30, 2021. We expect to make up the lost volume from this shut down in the fourth quarter of 2021.

Despite this shutdown, the COVID-19 pandemic has not materially adversely affected our manufacturing operations during the nine months ended September 30, 2020 due to reduced production levels at our manufacturing facilities primarily during the first and second quarters of 2020 as a result of certain applicable government-mandated stay at home orders in response to the COVID-19 pandemic, demands from certain of our labor unions to suspend or reduce production and general safety concerns of our associates. By the end of the second quarter of 2020, most2021. Although all of our manufacturing facilities ~~had returned to~~currently are operating at or near normal production ~~levels. For the third quarter of 2020, the COVID-19 pandemic did not have a material adverse impact on our operations and results of operations.~~

~~Several of our manufacturing facilities are operating in regions with high~~ levels, ~~of reported COVID-19 positive cases. As such,~~ we may be required to reinstate temporary production suspensions or volume reductions at ~~these manufacturing facilities or at~~ our ~~other~~ manufacturing facilities to the extent there ~~is a resurgence~~are new resurgences of COVID-19 cases in the regions where we operate or there is an outbreak of positive COVID-19 cases in any of our manufacturing facilities.

~~We continue to manage~~However, our ~~liquidity to ensure our long-term viability until~~global supply chain has been adversely affected by the COVID-19 pandemic ~~abates. During~~in 2021 and our global supply chain may continue to be adversely affected if the ~~nine months ended~~COVID-19 pandemic persists. In addition, certain of our customers directly control the purchase of certain key raw materials and components, including resin and carbon. In 2021, these customers have had challenges procuring adequate supplies of resin and carbon, which has had an adverse impact on our production volumes and results of operations.

We expect decreased demand for our wind blades from our customers during the remainder of 2021 and 2022. We believe this decrease in demand is due to the continued global renewable energy regulatory and policy uncertainty and raw material cost increases mentioned above. The result is an expected adverse impact to our Adjusted EBITDA in 2021 of approximately $33 million. We believe that general optimism around potential legislation in the U.S. to extend the Production Tax Credit (PTC) on a long-term basis is causing developers to delay project timelines in anticipation of being able to build projects at higher PTC levels once the expected extensions are in place.

We are forecasting to incur a total of approximately $45 million of restructuring and impairment charges associated with our global footprint alignment and consolidation in 2021 and 2022 relating to our China and North America operations, including our planned suspension of production at our Iowa manufacturing facility at the end of 2021. Approximately $30 million of the total is forecasted to be incurred in 2021, with the remainder in 2022. We are forecasting that approximately 15% of the restructuring charges will be non-cash.

We were not in compliance with our Total Net Leverage Ratio financial covenant as of September 30, ~~2020,~~2021, primarily due to the Mexico production delays and increased raw material costs and constraints described above. On November 8, 2021 (the Waiver Effective Date), we and the lenders that are parties to the Credit Agreement executed a limited waiver pursuant to which the lenders agreed to temporarily waive our compliance with this financial covenant from the Waiver Effective Date through December 8, 2021. We also must maintain domestic U.S. cash of at least $20.0 million and global available liquidity of at least $50.0 million as of the close of business on each Friday commencing as of November 5, 2021 through the maturity date of the Credit Agreement. From and after the Waiver Effective Date, we may not allow any of our subsidiaries that are not loan parties to the Credit Agreement to incur any additional indebtedness and we may not make any investment in any of its subsidiaries that are not loan parties to the Credit Agreement in an aggregate amount greater than $5.0 million. We had $68.3 million of domestic U.S cash and $132.9 million of global available liquidity as of October 29, 2021.

Given these near-term liquidity challenges, on November 8, 2021, we entered into a Series A Preferred Stock Purchase Agreement (the Purchase Agreement) with Oaktree Power Opportunities Fund V (Delaware) Holdings, L.P., OPPS TPIC Holdings, LLC, and Oaktree Phoenix Investment Fund L.P. (collectively, the Purchasers) pursuant to which we agreed to issue and sell to the Purchasers 350,000 shares of our newly designated Series A Preferred Stock, par value $0.01 per share, for an aggregate purchase price of $350.0 million. We expect the closing of this equity financing transaction to occur in the fourth quarter of 2021 and intend to use the net ~~borrowings~~proceeds from the issuance and sale of ~~$72.8 million~~the Series A Preferred Stock to repay all outstanding indebtedness under our Credit ~~Agreement. In addition,~~Agreement and the remainder for general corporate purposes. We also may elect at our option to require Oaktree to purchase an additional $50.0 million of Series A Preferred Stock upon the same terms and conditions as the initial issuance of the Series A Preferred Stock during the ~~nine months ended September 30, 2020, we entered into or amended four unsecured credit agreements with four Turkish~~two-year period following the Closing Date.

See Note 15, Subsequent Events, to our condensed consolidated financial ~~institutions resulting in net borrowings of $31.2 million and current availability of $44.0 million.~~

For the three and nine months ended September 30, 2020, we estimate that our net sales were adversely impacted by approximately $8 million and $142 million, based upon 13 and 342 wind blade sets which we had forecasted to produce in those periods under non-cancellable purchase orders associated with our long-term contracts but were unable to do so as a result of the COVID-19 pandemic.

For the three and nine months ended September 30, 2020 we estimate that our net income and net loss was adversely impacted by approximately $2 million, net of taxes, and $21 million, net of taxes, based upon the forecasted gross marginstatements for more details on the ~~forecasted wind blade sets which we were planning to produce in those periods but were unable to do so as a result of~~limited waiver and the COVID-19 pandemic. In addition, for the three and nine months ended September 30, 2020, we incurred approximately $4 million, net of taxes, and $11 million, net of taxes, of COVID-19 related costs associated with the health and safety of our associates and non-productive labor.Purchase Agreement.

For the three and nine months ended September 30, 2020, we estimate that our Adjusted EBITDA was adversely impacted by approximately $8 million and $55 million, respectively, based upon the forecasted Adjusted EBITDA margin on the forecasted wind blade sets which we were planning to produce in those periods but were unable to do so as a result of the COVID-19 pandemic and COVID-19 related costs associated with the health and safety of our associates and non-productive labor.

KEY METRICS USED BY MANAGEMENT TO MEASURE PERFORMANCE

For a detailed discussion of our key financial measures and our key operating metrics, refer to the discussion in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Key Metrics Used By Management To Measure Performance” included in Part II, Item 7 of our Annual Report on Form 10-K.

KEY FINANCIAL ~~METRICS~~MEASURES


	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2021			2020		2021			2020
	(in thousands)
Net sales	$	479,599		$	474,113	$	1,343,120		$	1,204,566
Net income (loss)		(30,677	)		42,382		(72,271	)		(24,211	)
EBITDA (1)		(6,478	)		27,168		3,221			21,819
Adjusted EBITDA (1)		179			49,131		30,635			53,722
Capital expenditures							30,138			53,428
Free cash flow (1)							(58,379	)		(19,563	)


	September 30,			December 31,
	2021			2020
	(in thousands)
Total debt, net of debt issuance costs	$	262,129		$	216,867
Net debt (1)		(143,833	)		(88,061	)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

(in thousands)

Net sales

$
474,113

$
383,836

$
1,204,566

$
1,014,387

Net income (loss)

$
42,382

$
(4,571
)

$
(24,211
)

$
(14,847
)
EBITDA ⁽¹⁾

$
27,168

$
26,302

$
21,819

$
33,876

Adjusted EBITDA⁽¹⁾

$
49,131

$
27,470

$
53,722

$
53,816

Capital expenditures

$
53,428

$
59,092

Free cash flow ⁽¹⁾

$
(19,563
)

$
3,643

(1)

See below for a reconciliation of EBITDA, adjusted EBITDA, free cash flow and net debt to net income (loss), net income (loss), net cash provided by (used in) operating activities and total debt, net of debt issuance costs, respectively, the most directly comparable financial measures calculated and presented in accordance with GAAP.

September 30,

December 31,

2020

2019

(in thousands)

Total debt, net of debt issuance costs

$
237,568

$
141,389

Net debt ⁽¹⁾

$
(89,311
)

$
(71,779
)

~~(1)~~

The following tables reconcile our non-GAAP key financial measures to the most directly comparable GAAP measures:

EBITDA and adjusted EBITDA are reconciled as follows:


	Three Months Ended						Nine Months Ended						Three Months Ended						Nine Months Ended
	September 30,						September 30,						September 30,						September 30,
	2020			2019			2020			2019			2021			2020			2021			2020
	(in thousands)												(in thousands)
Net income (loss)	$	42,382		$	(4,571	)	$	(24,211	)	$	(14,847	)	$	(30,677	)	$	42,382		$	(72,271	)	$	(24,211	)
Adjustments:
Depreciation and amortization		14,031			9,948			36,675			27,732			13,289			14,031	��		37,399			36,675
Interest expense (net of interest income)		3,093			2,087			7,409			6,278
Interest expense, net														2,662			3,093			8,057			7,409
Income tax provision (benefit)		(32,338	)		18,838			1,946			14,713			8,248			(32,338	)		30,036			1,946
EBITDA		27,168			26,302			21,819			33,876			(6,478	)		27,168			3,221			21,819
Share-based compensation expense		2,631			1,682			7,947			4,604			1,943			2,631			7,267			7,947
Realized gain (loss) on foreign currency remeasurement		17,127			(3,719	)		18,095			1,050
Realized loss on sale of assets and asset impairments		2,160			3,354			5,518			10,561
Restructuring charges (reversals), net		45			(149	)		343			3,725
Foreign currency loss (income)														(3,958	)		17,127			6,273			18,095
Loss on sale of assets and asset impairments														7,250			2,160			9,998			5,518
Restructuring charges, net														1,422			45			3,876			343
Adjusted EBITDA	$	49,131		$	27,470		$	53,722		$	53,816		$	179		$	49,131		$	30,635		$	53,722

Free cash flow is reconciled as follows:

	Nine Months Ended
	September 30,						Nine Months Ended
	2020			2019			September 30,
	(in thousands)						2021			2020
Net cash provided by operating activities	$	33,865		$	62,735
							(in thousands)
Net cash provided by (used in) operating activities							$	(28,241	)	$	33,865
Less capital expenditures		(53,428	)		(59,092	)		(30,138	)		(53,428	)
Free cash flow	$	(19,563	)	$	3,643		$	(58,379	)	$	(19,563	)

Net debt is reconciled as follows:


	September 30,			December 31,			September 30,			December 31,
	2020			2019			2021			2020
	(in thousands)						(in thousands)
Cash and cash equivalents	$	149,422		$	70,282		$	119,005		$	129,857
Less total debt, net of debt issuance costs		(237,568	)		(141,389	)		(262,129	)		(216,867	)
Less debt issuance costs		(1,165	)		(672	)		(709	)		(1,051	)
Net debt	$	(89,311	)	$	(71,779	)	$	(143,833	)	$	(88,061	)

KEY OPERATING METRICS


	Three Months Ended						Nine Months Ended						Three Months Ended						Nine Months Ended
	September 30,						September 30,						September 30,						September 30,
	2020			2019			2020			2019			2021			2020			2021			2020
Sets		1,038		��	858			2,556			2,236			830			1,037			2,487			2,556
Estimated megawatts		3,576			2,491			8,555			6,381			3,395			3,571			9,770			8,555
Utilization		93	%		88	%		78	%		74	%		76	%		93	%		78	%		78	%
Dedicated manufacturing lines		55			52			55			54			54			55			54			55
Manufacturing lines installed		54			48			54			48			54			54			54			54

~~Results of Operations~~ RESULTS OF OPERATIONS

The following table summarizes our ~~condensed consolidated statements of operations~~operating results as a percentage of net sales for the three and nine months ended September 30, 2021 and 2020 ~~and 2019:~~ that have been derived from our condensed consolidated statements of operations:


	Three Months Ended								Nine Months Ended								Three Months Ended								Nine Months Ended
	September 30,								September 30,								September 30,								September 30,
	2020				2019				2020				2019				2021				2020				2021				2020
Net sales		100.0		%		100.0		%		100.0		%		100.0		%		100.0		%		100.0		%		100.0		%		100.0		%
Cost of sales		89.7				87.5				94.8				89.1				98.5				89.7				96.5				94.8
Startup and transition costs		1.8				5.7				2.6				6.3				3.0				1.8				2.9				2.6
Total cost of goods sold		91.5				93.2				97.4				95.4				101.5				91.5				99.4				97.4
Gross profit		8.5				6.8				2.6				4.6
Gross profit (loss)																		(1.5	)			8.5				0.6				2.6
General and administrative expenses		2.0				2.8				2.1				2.7				1.7				2.0				1.8				2.1
Realized loss on sale of assets and asset impairments		0.4				0.9				0.5				1.0
Restructuring charges (reversals), net		0.0				(0.1	)			0.0				0.4
Income from operations		6.1				3.2				0.0				0.5
Loss on sale of assets and asset impairments																		1.5				0.4				0.7				0.5
Restructuring charges, net																		0.3				0.0				0.3				0.0
Income (loss) from operations																		(5.0	)			6.1				(2.2	)			0.0
Total other income (expense)		(4.0	)			0.5				(1.9	)			(0.5	)			0.3				(4.0	)			(1.0	)			(1.9	)
Income (loss) before income taxes		2.1				3.7				(1.9	)			0.0				(4.7	)			2.1				(3.2	)			(1.9	)
Income tax benefit (provision)		6.8				(4.9	)			(0.1	)			(1.5	)			(1.7	)			6.8				(2.2	)			(0.1	)
Net income (loss)		8.9		%		(1.2	)	%		(2.0	)	%		(1.5	)	%		(6.4	)	%		8.9		%		(5.4	)	%		(2.0	)	%

Net sales

Consolidated discussion

The following table summarizes our net sales by ~~product~~product/service for the three and nine months ended September 30, ~~2020~~2021 and ~~2019 :~~2020:


	Three Months Ended										Nine Months Ended										Three Months Ended										Nine Months Ended
	September 30,				Change						September 30,				Change						September 30,				Change						September 30,				Change
	2020		2019		$			%			2020		2019		$			%			2021		2020		$			%			2021		2020		$		%
	(in thousands)										(in thousands)										(in thousands)										(in thousands)
Wind blade sales	$	450,135	$	352,202	$	97,933			27.8	%	$	1,134,535	$	930,916	$	203,619			21.9	%	$	450,725	$	450,135	$	590			0.1	%	$	1,248,608	$	1,134,535	$	114,073		10.1	%
Precision molding and assembly systems sales		10,541		15,049		(4,508	)		-30.0	%		24,198		39,176		(14,978	)		-38.2	%		8,383		10,541		(2,158	)		-20.5	%		30,913		24,198		6,715		27.8	%
Transportation sales		7,007		8,061		(1,054	)		-13.1	%		28,798		20,717		8,081			39.0	%		6,815		7,007		(192	)		-2.7	%		29,861		28,798		1,063		3.7	%
Other sales		6,430		8,524		(2,094	)		-24.6	%		17,035		23,578		(6,543	)		-27.8	%		13,676		6,430		7,246			112.7	%		33,738		17,035		16,703		98.1	%
Total net sales	$	474,113	$	383,836	$	90,277			23.5	%	$	1,204,566	$	1,014,387	$	190,179			18.7	%	$	479,599	$	474,113	$	5,486			1.2	%	$	1,343,120	$	1,204,566	$	138,554		11.5	%

~~The increase in the net~~29

Net sales of wind blades ~~was primarily driven by a 20% increase in the number of wind blades produced~~ during the three months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019 as a result~~2020, were relatively flat. Net sales of ~~increased production at our China, Mexico, Iowa and India facilities. This increase was also due to~~wind blades during the three months ended September 30, 2021 were positively impacted by a higher average sales price due to the mix of wind blade models produced, ~~during~~an increase in the ~~three months ended September 30, 2020 compared to~~year over year number of wind blades still in the ~~same~~production process at the end of the period, ~~in 2019. Net sales from the manufacturing of precision molding~~ and ~~assembly systems during the three months ended September 30, 2020 decreased by $4.5 million as compared to the same period in 2019.~~foreign currency fluctuations. Additionally, ~~there was a $3.1 million decrease in transportation and other~~when comparing our net sales during the three months ended September 30, 2021, against the comparable prior year period, our current year net sales were negatively impacted by the removal of five contracted manufacturing lines that expired in China at the end of 2020 as ~~compared~~well as a further reduction of two contracted manufacturing lines in China in 2021, reduced production volumes resulting from certain of our customers’ challenges in procuring adequate supplies of resin and carbon, significant production delays that occurred at one of our Juarez, Mexico manufacturing facilities related to an ongoing transition, and a temporary shutdown of our Yangzhou manufacturing facility due to a COVID-19 outbreak in Yangzhou City, which was partially offset by the ~~same period~~adverse impact that the COVID-19 pandemic had on our net sales in ~~2019.~~the prior year period. The reasons set forth above were the primary drivers of the 20% decrease in the number of wind blades produced year over year. The fluctuating U.S. dollar against the Euro in our Turkey operations and the Chinese Renminbi in our China operations had a favorable impact of ~~0.7%~~0.3% on consolidated net sales for the three months ended September 30, 2021, as compared to the 2020 period.

The increase in net sales of wind blades during the nine months ended September 30, 2021, as compared to the same period in ~~2019. Although our net sales increased for the three months ended September 30,~~ 2020, compared to the same period in 2019, we estimate that our net sales were adversely impacted by approximately $8 million, based upon 13 wind blade sets, which we had forecasted to produce in the period under non-cancellable purchase orders associated with our long-term contracts but were unable to do so as a result of the COVID-19 pandemic.

~~The increase in the net sales of wind blades~~ was primarily driven by a 14% increase in the number of wind blades produced during the nine months ended September 30, 2020 compared to the same period in 2019 as a result of increased production at our China, Mexico, Iowa and India facilities. The increase was also due to a higher average sales price due to the mix of wind blade models produced ~~during the nine months ended September 30, 2020 compared to the same period in 2019. Net sales from the manufacturing of precision molding~~ and ~~assembly systems during the nine months ended September 30, 2020 decreased by $15.0 million as compared to the same period in 2019.~~ foreign currency fluctuations.

Additionally, ~~there was a $1.5 million increase in transportation and other~~when comparing our net sales during the nine months ended September 30, 2021, against the comparable prior year period, our current year net sales were negatively impacted by the removal of five contracted manufacturing lines that expired in China at the end of 2020 as ~~compared~~well as a further reduction of two contracted manufacturing lines in China in 2021, reduced production volumes resulting from certain of our customers’ challenges in procuring adequate supplies of resin and carbon, and significant production delays that occurred at one of our Juarez, Mexico manufacturing facilities related to an ongoing transition, which was partially offset by the ~~same period~~adverse impact that the COVID-19 pandemic had on our net sales in ~~2019.~~the prior year period. The reasons set forth above, mostly offset by increased production at our India, Turkey and Mexico facilities were the primary drivers of the 3% decrease in the number of wind blades produced year over year. The fluctuating U.S. dollar against the Euro in our Turkey operations and the Chinese Renminbi in our China operations had ~~an unfavorable~~a favorable impact of ~~0.1%~~1.2% on consolidated net sales for the nine months ended September 30, ~~2020~~2021, as compared to ~~2019. Although our net sales increased for~~ the ~~nine months ended September 30,~~ 2020 compared to the same periods in 2019, we estimate that our net sales were adversely impacted by approximately $142 million, based upon 342 wind blade sets, which we had forecasted to produce at our Mexico, China, Iowa, Turkey and India manufacturing facilities in the periods under non-cancellable purchase orders associated with our long-term contracts but were unable to do so as a result of the COVID-19 pandemic. The COVID-19 pandemic required these manufacturing facilities to either temporarily suspend production or operate at reduced production levels period.~~primarily during the first and second quarters of 2020 as a result of certain applicable government-mandated stay at home orders~~ ~~in response to the COVID-19 pandemic, demands from certain of our labor unions to suspend or reduce production and general safety concerns of our associates.~~

Segment discussion

The following table summarizes our net sales by our ~~four~~five geographic operating segments for the three and nine months ended September 30, ~~2020~~2021 and ~~2019 :~~2020:


	Three Months Ended										Nine Months Ended										Three Months Ended										Nine Months Ended
	September 30,				Change						September 30,				Change						September 30,				Change						September 30,				Change
	2020		2019		$			%			2020		2019		$			%			2021		2020		$			%			2021		2020		$			%
	(in thousands)										(in thousands)										(in thousands)										(in thousands)
U.S.	$	46,799	$	40,643	$	6,156			15.1	%	$	136,309	$	122,129	$	14,180			11.6	%	$	47,702	$	46,799	$	903			1.9	%	$	153,749	$	136,309	$	17,440			12.8	%
Asia		163,458		108,114		55,344			51.2	%		400,513		261,531		138,982			53.1	%		51,869		163,458		(111,589	)		-68.3	%		219,903		400,513		(180,610	)		-45.1	%
Mexico		161,563		117,690		43,873			37.3	%		363,233		297,717		65,516			22.0	%		200,332		161,563		38,769			24.0	%		461,961		363,233		98,728			27.2	%
EMEAI		102,293		117,389		(15,096	)		-12.9	%		304,511		333,010		(28,499	)		-8.6	%
EMEA																						129,444		83,640		45,804			54.8	%		347,160		260,138		87,022			33.5	%
India																						50,252		18,653		31,599			169.4	%		160,347		44,373		115,974		NM
Total net sales	$	474,113	$	383,836	$	90,277			23.5	%	$	1,204,566	$	1,014,387	$	190,179			18.7	%	$	479,599	$	474,113	$	5,486			1.2	%	$	1,343,120	$	1,204,566	$	138,554			11.5	%

NM - not meaningful

U.S. Segment

The following table summarizes our net sales by ~~product~~product/service for the U.S. segment for the three and nine months ended September 30, 2021 and 2020:


	Three Months Ended										Nine Months Ended
	September 30,				Change						September 30,				Change
	2021		2020		$			%			2021		2020		$			%
	(in thousands)										(in thousands)
Wind blade sales	$	35,154	$	37,272	$	(2,118	)		-5.7	%	$	114,208	$	99,514	$	14,694			14.8	%
Transportation sales		3,621		6,206		(2,585	)		-41.7	%		22,272		27,424		(5,152	)		-18.8	%
Other sales		8,927		3,321		5,606			168.8	%		17,269		9,371		7,898			84.3	%
Total net sales	$	47,702	$	46,799	$	903			1.9	%	$	153,749	$	136,309	$	17,440			12.8	%

The decrease in the U.S. segment’s net sales of wind blades during the three months ended September 30, 2021, as compared to the same period in 2020, ~~and 2019:~~was primarily due to a 9% decrease in the number of wind blades produced, primarily related to volume reductions in anticipation of the suspension of production at our Newton, Iowa facility by the end of 2021. This net sales decrease was partially offset by a higher average sales price of wind blade models produced in the two comparative periods.

Three Months Ended

Nine Months Ended

September 30,

Change

September 30,

Change

2020

2019

$

%

2020

2019

$

%

(in thousands)

(in thousands)

Wind blade sales

$
37,272

$
25,857

$
11,415

44.1
%

$
99,514

$
84,328

$
15,186

18.0
%
Precision molding and
assembly systems sales

—

1,479

(1,479
)

NM

—

2,845

(2,845
)

NM

Transportation sales

6,206

8,061

(1,855
)

-23.0
%

27,424

20,717

6,707

32.4
%
Other sales

3,321

5,246

(1,925
)

-36.7
%

9,371

14,239

(4,868
)

-34.2
%
Total net sales

$
46,799

$
40,643

$
6,156

15.1
%

$
136,309

$
122,129

$
14,180

11.6
%

~~NM - not meaningful~~

The increase in the U.S. segment’s net sales of wind blades during the nine months ended September 30, 2021, as compared to the same period in 2020, was primarily due to a 7% increase in the number of wind blades produced, primarily due to the adverse impact of the COVID-19 pandemic in the prior year period, as well as a higher average sales price ~~due to the mix~~ of wind blade models produced in the two comparative periods as well as a 57% increase in the number of wind blades produced in the three months ended September 30, 2020 as compared to the same period in 2019. Net sales from the manufacturing of precision molding and assembly systems during the three months ended September 30, 2020 decreased by $1.5 million as compared to the same period in 2019. Additionally, there was a $3.8 million decrease in transportation and other sales during the three months ended September 30, 2020 as compared to the same period in 2019.periods.

The increase in the U.S. segment’s net sales of wind blades was primarily due to a higher average sales price due to the mix of wind blade models produced in the two comparative periods as well as a 17% increase in the number of wind blades produced in the nine months ended September 30, 2020 as compared to the same period in 2019. Although our U.S. net sales increased for the nine months ended September 30, 2020 compared to the same period in 2019, our U.S. net sales were adversely impacted due to reduced production levels at our U.S. manufacturing facilities due to the COVID-19 pandemic primarily during the second quarter of 2020. Net sales from the manufacturing of precision molding and assembly systems during the nine months ended September 30, 2020 decreased by $2.8 million as compared to the same period in 2019. Additionally, there was a $1.8 million increase in transportation and other sales during the nine months ended September 30, 2020 as compared to the same period in 2019.

Asia Segment

The following table summarizes our net sales by ~~product~~product/service for the Asia segment for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended										Nine Months Ended										Three Months Ended										Nine Months Ended
	September 30,				Change						September 30,				Change						September 30,				Change						September 30,				Change
	2020		2019		$			%			2020		2019		$			%			2021		2020		$			%			2021		2020		$			%
	(in thousands)										(in thousands)										(in thousands)										(in thousands)
Wind blade sales	$	158,120	$	98,406	$	59,714			60.7	%	$	385,536	$	238,947	$	146,589			61.3	%	$	47,187	$	158,120	$	(110,933	)		-70.2	%	$	202,181	$	385,536	$	(183,355	)		-47.6	%
Precision molding and assembly systems sales		4,451		8,915		(4,464	)		-50.1	%		13,088		20,856		(7,768	)		-37.2	%		3,869		4,451		(582	)		-13.1	%		15,467		13,088		2,379			18.2	%
Other sales		887		793		94			11.9	%		1,889		1,728		161			9.3	%		813		887		(74	)		-8.3	%		2,255		1,889		366			19.4	%
Total net sales	$	163,458	$	108,114	$	55,344			51.2	%	$	400,513	$	261,531	$	138,982			53.1	%	$	51,869	$	163,458	$	(111,589	)		-68.3	%	$	219,903	$	400,513	$	(180,610	)		-45.1	%

The ~~increase~~decrease in the Asia segment’s net sales of wind blades ~~reflects~~during the three months ended September 30, 2021, as compared to the same period in 2020, was primarily due to a ~~32%~~71% decrease in the number of wind blades produced, primarily due to the removal of five contracted manufacturing lines that expired in China at the end of 2020, a further reduction of contracted manufacturing lines in 2021 in China, and a temporary shutdown of our Yangzhou manufacturing facility due to a COVID-19 outbreak in Yangzhou City. Additionally, for the three months ended September 30, 2021, there was a decrease in the period over period number of wind blades still in the production process at the end of the period. The net ~~increase in overall wind blade volume and~~sales decrease during the three months ended September 30, 2021 was partially offset by an increase in the average sales price of wind blades due to a change in the mix of wind blades produced in the two comparative periods. ~~Net sales from the manufacturing of precision molding and assembly systems decreased by $4.5 million during the three months ended September 30, 2020 as compared to the same period in 2019.~~

The ~~increase~~decrease in the Asia segment’s net sales of wind blades during the nine months ended September 30, 2021, as compared to the same period in 2020, was primarily due to a ~~37% net increase~~49% decrease in the number of wind blades produced, primarily due to the removal of five contracted manufacturing lines that expired in China at the end of 2020 and a further reduction of contracted manufacturing lines in 2021 in China, which was partially offset by the adverse impact that the COVID-19 pandemic had on our net sales in the prior year period. The net sales decrease during the nine months ended September 30, ~~2020 as compared to the same period in 2019 and~~2021 was partially offset by an increase in the average sales price of wind blades due to a change in the mix of wind blades produced in the two comparative periods. ~~Although~~The fluctuating U.S. dollar against the Chinese Renminbi in our ~~Asia~~China operations had a favorable impact of 0.1% on consolidated net sales ~~increased~~ for the nine months ended September 30, 2020 compared to the same period in 2019, our Asia net sales were adversely impacted due to reduced production levels at our Asia manufacturing facilities due to the COVID-19 pandemic primarily during the first quarter of 2020. Net sales from the manufacturing of precision molding and assembly systems decreased by $7.8 million during the 2020 period2021, as compared to the ~~same period in 2019.~~2020 period.

Mexico Segment

The following table summarizes our net sales by ~~product~~product/service for the Mexico segment for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended										Nine Months Ended										Three Months Ended										Nine Months Ended
	September 30,				Change						September 30,				Change						September 30,				Change						September 30,				Change
	2020		2019		$			%			2020		2019		$			%			2021		2020		$			%			2021		2020		$		%
	(in thousands)										(in thousands)										(in thousands)										(in thousands)
Wind blade sales	$	153,575	$	111,855	$	41,720			37.3	%	$	346,954	$	278,685	$	68,269			24.5	%	$	191,499	$	153,575	$	37,924			24.7	%	$	431,129	$	346,954	$	84,175		24.3	%
Precision molding and assembly systems sales		6,090		4,655		1,435			30.8	%		11,110		15,475		(4,365	)		-28.2	%		4,514		6,090		(1,576	)		-25.9	%		15,446		11,110		4,336		39.0	%
Transportation sales		801		—		801		NM				1,374		—		1,374		NM				3,194		801		2,393		NM				7,589		1,374		6,215	NM
Other sales		1,097		1,180		(83	)		-7.0	%		3,795		3,557		238			6.7	%		1,125		1,097		28			2.6	%		7,797		3,795		4,002		105.5	%
Total net sales	$	161,563	$	117,690	$	43,873			37.3	%	$	363,233	$	297,717	$	65,516			22.0	%	$	200,332	$	161,563	$	38,769			24.0	%	$	461,961	$	363,233	$	98,728		27.2	%

The increase in the Mexico segment’s net sales of wind blades reflects a 26% increase in overall wind blade volume and an increase in the average sales price of wind blades due to a change in the mix of wind blades produced in the two comparative periods. Net sales from the manufacturing of precision molding and assembly systems during the three months ended September 30, ~~2020 increased by $1.4 million~~2021, as compared to the same period in ~~2019.~~

~~The increase in the Mexico segment’s net sales of wind blades~~2020, reflects ~~a 17% net increase in overall wind blade volume,~~ an increase in the average sales price of wind blades due to a change in the mix of wind blades produced in the two comparative periods and the Matamoros strike in 2019. Although our Mexico net sales increased for the nine months ended September 30, 2020 compared to the same period in 2019, our Mexico net sales were adversely impacted due to reduced production levels at our Mexico manufacturing facilities due to the COVID-19 pandemic primarily during the second quarter of 2020. Net sales from the manufacturing of precision molding and assembly systems during the nine months ended September 30, 2020 decreased by $4.4 million as compared to the sameover period ~~in 2019.~~

~~EMEAI Segment~~

~~The following table summarizes our net sales by product for the EMEAI segment for the three and nine months ended September 30, 2020 and 2019:~~

Three Months Ended

Nine Months Ended

September 30,

Change

September 30,

Change

2020

2019

$

%

2020

2019

$

%

(in thousands)

(in thousands)

Wind blade sales

$
101,168

$
116,084

$
(14,916
)

-12.8
%

$
302,531

$
328,956

$
(26,425
)

-8.0
%
Other sales

1,125

1,305

(180
)

-13.8
%

1,980

4,054

(2,074
)

-51.2
%
Total net sales

$
102,293

$
117,389

$
(15,096
)

-12.9
%

$
304,511

$
333,010

$
(28,499
)

-8.6
%

The decrease in the EMEAI segment’s net sales of wind blades was driven by a 10% net decrease in wind blade volume primarily at our two Turkey manufacturing facilities due to transitions and a decrease in the year over year number of wind blades still in the production process at the end of the ~~period. The decrease was partially offset by~~period, as well as an increase in the average sales price of wind blades due to the mix of wind blades produced in the two comparative ~~periods and foreign currency fluctuations. The fluctuating U.S. dollar relative to the Euro had a favorable impact of 3.2% on~~periods. These net sales ~~during the three months ended September 30, 2020 as compared to 2019.~~

~~The~~increases were partially offset by a 17% net decrease in overall wind blade volume, primarily due to significant production delays that occurred at one of our Juarez, Mexico manufacturing facilities related to customer supplied specialized equipment and supply constraints affecting carbon in connection with the ~~EMEAI~~ongoing transition to an innovative new blade for one of our customers and production delays resulting from one of our customer's challenges in procuring adequate supplies of carbon at one of our Matamoros, Mexico manufacturing facilities.

The increase in the Mexico segment’s net sales of wind blades ~~was driven by~~during the nine months ended September 30, 2021, as compared to the same period in 2020, reflects a ~~14%~~5% net ~~decrease~~increase in overall wind blade ~~production~~volume, primarily ~~at our two Turkey manufacturing facilities due to transitions and reduced production levels at these manufacturing facilities~~ due to the adverse impact of the COVID-19 pandemic ~~primarily during~~in the ~~second quarter of 2020. The decrease was~~prior year period partially offset by the production delays described above, an increase in the ~~average sales price of wind blades delivered in the comparative periods and an increase in the year~~period over ~~year~~period number of wind blades still in the production process at the end of the ~~period.~~period, as well as an increase in the average sales price of wind blades due to the mix of wind blades produced in the two comparative periods.

EMEA Segment

The following table summarizes our net sales by product/service for the EMEA segment for the three and nine months ended September 30, 2021 and 2020:


	Three Months Ended									Nine Months Ended
	September 30,				Change					September 30,				Change
	2021		2020		$		%			2021		2020		$		%
	(in thousands)									(in thousands)
Wind blade sales	$	126,705	$	82,550	$	44,155		53.5	%	$	340,933	$	258,193	$	82,740		32.0	%
Other sales		2,739		1,090		1,649		151.3	%		6,227		1,945		4,282	NM
Total net sales	$	129,444	$	83,640	$	45,804		54.8	%	$	347,160	$	260,138	$	87,022		33.5	%

The increase in the EMEA segment’s net sales of wind blades during the three and nine months ended September 30, 2021, as compared to the same periods in 2020, was driven by a 32% and 20% increase in wind blade production at our two Turkey plants, respectively, primarily due to transitions and the adverse impact of the COVID-19 pandemic in the prior year, as well as an increase in the average sales price of wind blades produced in the two comparative periods and foreign currency fluctuations. These net sales increases were partially offset by reduced production volumes resulting from one of our customer's challenges in procuring adequate supplies of resin and carbon. The fluctuating U.S. dollar relative to the Euro had ~~an unfavorable~~a favorable impact of ~~0.2%~~1.0% and 4.5% on net sales during the three and nine months ended September 30, ~~2020~~2021, respectively, as compared to the ~~2019 period.~~2020 periods.

India Segment

The following table summarizes our net sales by product/service for the India segment for the three and nine months ended September 30, 2021 and 2020:


	Three Months Ended									Nine Months Ended
	September 30,				Change					September 30,				Change
	2021		2020		$		%			2021		2020		$		%
	(in thousands)									(in thousands)
Wind blade sales	$	50,180	$	18,618	$	31,562		169.5	%	$	160,157	$	44,338	$	115,819	NM
Other sales		72		35		37		105.7	%		190		35		155	NM
Total net sales	$	50,252	$	18,653	$	31,599		169.4	%	$	160,347	$	44,373	$	115,974	NM

The increase in the India segment’s net sales of wind blades during the three and nine months ended September 30, 2021, as compared to the same period in 2020, was primarily driven by the commencement of production for one of our customers in 2020, and the ramp up of such production in 2021.

Total cost of goods sold

The following table summarizes our total cost of goods sold for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended												Nine Months Ended												Three Months Ended												Nine Months Ended
	September 30,						Change						September 30,						Change						September 30,						Change						September 30,						Change
	2020			2019			$			%			2020			2019			$			%			2021			2020			$			%			2021			2020			$			%
	(in thousands)												(in thousands)												(in thousands)												(in thousands)
Cost of sales	$	425,064		$	335,778		$	89,286			26.6	%	$	1,141,183		$	904,135		$	237,048			26.2	%	$	472,188		$	425,064		$	47,124			11.1	%	$	1,295,660		$	1,141,183		$	154,477			13.5	%
Startup and transition costs		8,576			22,127			(13,551	)		-61.2	%		31,530			63,206			(31,676	)		-50.1	%
Startup costs																										4,521			5,142			(621	)		-12.1	%		13,577			19,895			(6,318	)		-31.8	%
Transition costs																										10,020			3,434			6,586			191.8	%		25,417			11,635			13,782			118.5	%
Total startup and transition costs																										14,541			8,576			5,965			69.6	%		38,994			31,530			7,464			23.7	%
Total cost of goods sold	$	433,640		$	357,905		$	75,735			21.2	%	$	1,172,713		$	967,341		$	205,372			21.2	%	$	486,729		$	433,640		$	53,089			12.2	%	$	1,334,654		$	1,172,713		$	161,941			13.8	%
% of net sales		91.5	%		93.2	%					-1.7	%		97.4	%		95.4	%					2.0	%		101.5	%		91.5	%					10.0	%		99.4	%		97.4	%					2.0	%

Total cost of goods sold for the three months ended September 30, 2020 was $433.6 million and included $5.2 million related to lines in startup and $3.4 million of transition costs related to lines in transition during the quarter. This compares to total cost of goods sold for the three months ended September 30, 2019 of $357.9 million and included $13.1 million related to lines in startup and $9.0 million of transition costs related to lines in transition during the quarter. Total cost of goods sold as a percentage of net sales ~~decreased~~increased by approximately 2%ten percentage points during the three months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019,~~2020, driven primarily by ~~the decrease~~increases in direct ~~materials, the impact of savings in raw~~ material costs, ~~the decrease in startup and transition~~direct labor costs and foreign currency fluctuations. The significant production delays that occurred at the Matamoros, Mexico manufacturing facility, which we took over from Nordex in July 2021, during the three months ended September 30, 2021 were a major contributor to this increase. The fluctuating U.S. dollar against the Euro, Turkish Lira, Chinese Renminbi and Mexican Peso had ~~a favorable~~an unfavorable impact of ~~1.1%~~0.5% on consolidated cost of goods sold for the three months ended September 30, ~~2020~~2021 as compared to the ~~same period in 2019.~~2020 period.

Total cost of goods sold for the nine months ended September 30, 2020 was $1,172.7 million and included $19.9 million related to lines in startup and $11.6 million of transition costs related to the lines in transition during the period. This compares to total cost of goods sold for the nine months ended September 30, 2019 of $967.3 million and included $43.9 million related to lines in startup and $19.3 million of transition costs related to lines in transition during the period. Cost of goods sold as a percentage of net sales increased by approximately 2%two percentage points during the nine months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019,~~2020, driven primarily by ~~the~~an increase in ~~warranty~~direct material costs ~~primarily relating to a remediation campaign for a specific wind blade model for one of our customers,~~ and ~~COVID-19 related costs associated with the health and safety of our associates and non-productive labor,~~foreign currency fluctuations, partially offset by a decrease in ~~startup and transition costs, the impact of savings in raw material costs and foreign currency fluctuations.~~warranty costs. The fluctuating U.S. dollar against the Euro, Turkish Lira, Chinese Renminbi and Mexican Peso had ~~a favorable~~an unfavorable impact of ~~2.0%~~1.2% on consolidated cost of goods sold for the nine months ended September 30, ~~2020~~2021, as compared to ~~2019.~~the 2020 period.

General and administrative expenses

The following table summarizes our general and administrative expenses for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended												Nine Months Ended												Three Months Ended												Nine Months Ended
	September 30,						Change						September 30,						Change						September 30,						Change						September 30,						Change
	2020			2019			$			%			2020			2019			$			%			2021			2020			$			%			2021			2020			$			%
	(in thousands)												(in thousands)												(in thousands)												(in thousands)
General and administrative expenses	$	9,263		$	10,608		$	(1,345	)		-12.7	%	$	25,646		$	27,801		$	(2,155	)		-7.8	%	$	8,185		$	9,263		$	(1,078	)		-11.6	%	$	23,819		$	25,646		$	(1,827	)		-7.1	%
% of net sales		2.0	%		2.8	%					-0.8	%		2.1	%		2.7	%					-0.6	%		1.7	%		2.0	%					-0.3	%		1.8	%		2.1	%					-0.3	%

The decrease in general and administrative expenses as a percentage of net sales ~~in both periods of 2020~~for the three and nine months ended September 30, 2021, as compared to the same periods in ~~2019 was~~2020, were primarily driven by ~~lower travel and training costs due to the COVID-19 pandemic.~~ our continued focus on reducing costs.

~~Realized loss~~Loss on sale of assets and asset impairments

The ~~following table summarizes our realized~~increase in the loss on sale of assets and asset impairments for the three and nine months ended September 30, ~~2020 and 2019:~~

Three Months Ended

Nine Months Ended

September 30,

Change

September 30,

Change

2020

2019

$

%

2020

2019

$

%

(in thousands)

(in thousands)

Realized loss on sale
of assets and asset
impairments

$
2,160

$
3,354

$
(1,194
)

-35.6
%

$
5,518

$
10,561

$
(5,043
)

-47.8
%
% of net sales

0.5
%

0.9
%

-0.4
%

0.5
%

1.0
%

-0.5
%

The decrease in the realized loss on sale of assets and asset impairments for the three months ended September 30, 2020 was primarily the result of lower realized losses on the sale of receivables under supply chain financing arrangements with our customers in the current year period due to decreasing interest rates2021, as compared to the ~~equivalent prior year period.~~same periods in 2020, were primarily driven by asset impairment charges of $5.9 million incurred at our Newton, Iowa blade facility related to the plant's expected shutdown at the end of the year.

Restructuring costs, net

The ~~decrease~~increase in ~~the realized loss on sale of assets and asset impairments~~restructuring costs, net for the three and nine months ended September 30, 2020 was primarily due to $5.0 million of realized losses on the sale of assets at our corporate and manufacturing facilities in the 2019 period as compared to $0.8 million of such losses in the 2020 period, as well as the result of lower realized losses on the sale of receivables under supply chain financing arrangements with our customers in the current year period due to decreasing interest rates2021, as compared to the ~~equivalent prior year period.~~same periods in 2020, were associated with the optimization of our global footprint, comprised of $1.4 million and $3.9 million, respectively, of

~~Restructuring charges (reversals), net~~

~~Restructuring charges for~~severance benefits to terminated employees. We expect that all of the ~~three months ended September 30, 2020 totaled $0.1 million compared to a reversal of $0.1 million for the same period in 2019. The 2019 reversal related~~severance benefits will be paid to the ~~wind down~~terminated employees by the end of ~~our Fall River, Massachusetts facility.~~November 2021.

Restructuring charges for the nine months ended September 30, 2020 totaled $0.3 million compared to $3.7 million for the same period in 2019. The 2019 restructuring costs primarily related to the closing and moving of our Taicang City, China tooling facility to our Taicang Port, China facility.

Income (loss) from operations

Segment discussion

The following table summarizes our income (loss) from operations by our ~~four~~five geographic operating segments for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended												Nine Months Ended												Three Months Ended												Nine Months Ended
	September 30,						Change						September 30,						Change						September 30,						Change						September 30,						Change
	2020			2019			$			%			2020			2019			$			%			2021			2020			$			%			2021			2020			$			%
	(in thousands)												(in thousands)												(in thousands)												(in thousands)
U.S.	$	(6,360	)	$	(17,510	)	$	11,150			63.7	%	$	(33,991	)	$	(54,235	)	$	20,244			37.3	%	$	(24,598	)	$	(6,360	)	$	(18,238	)	NM			$	(36,070	)	$	(33,991	)	$	(2,079	)		-6.1	%
Asia		25,779			13,448			12,331			91.7	%		49,343			4,779			44,564		NM				(3,607	)		25,779			(29,386	)		-114.0	%		7,207			49,343			(42,136	)		-85.4	%
Mexico		11,986			(4,954	)		16,940		NM				(1,106	)		(1,258	)		152			12.1	%		(3,802	)		11,986			(15,788	)		-131.7	%		(33,082	)		(1,106	)		(31,976	)	NM
EMEAI		(2,400	)		21,134			(23,534	)		-111.4	%		(13,900	)		55,673			(69,573	)		-125.0	%
Total income from operations	$	29,005		$	12,118		$	16,887			139.4	%	$	346		$	4,959		$	(4,613	)		-93.0	%
EMEA																										9,423			1,795			7,628		NM				29,993			3,314			26,679		NM
India																										(1,403	)		(4,195	)		2,792			66.6	%		2,725			(17,214	)		19,939			115.8	%
Total income (loss) from operations																									$	(23,987	)	$	29,005		$	(52,992	)		-182.7	%	$	(29,227	)	$	346		$	(29,573	)	NM
% of net sales		6.1	%		3.2	%					2.9	%		0.0	%		0.5	%					-0.5	%		-5.0	%		6.1	%					-11.1	%		-2.2	%		0.0	%					-2.2	%

U.S. Segment

The ~~decrease~~increase in the loss from operations in the U.S. segment for the three months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019~~2020, was primarily due to the ~~decreased costs related to the shutdown of our Newton, Iowa transportation facility, the~~ decrease in ~~transition~~wind blade volume, an increase in direct material and direct labor costs and impairment charges incurred at our Newton, Iowa blade facility ~~a decrease in direct material costs, and~~related to the ~~increase in wind blade volume and~~suspension of production by the end of 2021, partially offset by an increase in the average sales price of wind blades ~~noted above.~~produced.

The ~~decrease~~increase in the loss from operations in the U.S. segment for the nine months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019~~2020, was primarily due to ~~the decreased~~an increase in direct material costs ~~related to the shutdown of our Newton, Iowa transportation facility~~ and ~~the decrease in transition costs~~impairment charges incurred at our Newton, Iowa blade facility related to the ~~increase in wind blade volume and increase in~~suspension of production by the ~~average sales~~

~~price~~end of ~~wind blades noted above,~~2021, partially offset by increased direct material and direct labor costs and at our Newton, Iowa blade facility. Although our U.S. loss from operations decreased for the nine months ended September 30, 2020 compared to the same period in 2019, our income from operations for the nine months ended September 30, 2020 was adversely impacted due to reduced production levels at our U.S. blade manufacturing facility due to the COVID-19 pandemic during the second quarter of 2020 and COVID-19 related costs associated with the health and safety of our associates and non-productive labor.

~~Asia Segment~~

The increase in the income from operations in the Asia segment for the three months ended September 30, 2020 as compared to the same period in 2019 was primarily due to the net increase in overall wind blade volume, an increase in the average sales price of wind blades noted above, a decrease in startup and transition costs, and lower direct labor costs, partially offset by increased direct material costs due to a change in the mix of wind blade models produced in the two periods. The fluctuating U.S. dollar against the Chinese Renminbi had an unfavorable impact of 1.3% on cost of goods sold for the three months ended September 30, 2020 as compared to the same period in 2019.

The increase in the income from operations in the Asia segment for the nine months ended September 30, 2020 as compared to the same period in 2019 was primarily due to the net increase in overall wind blade volume, an increase in the average sales price of wind blades noted above, a decrease in the startup and transition costs, foreign currency fluctuations and lower direct labor costs. The fluctuating U.S. dollar against the Chinese Renminbi had a favorable impact of 1.2% on cost of goods sold for the nine months ended September 30, 2020 as compared to the 2019 period. Although our Asia income from operations increased for the nine months ended September 30, 2020 compared to the same period in 2019, our income from operations was adversely impacted due to reduced production levels at our Asia manufacturing facilities due to the COVID-19 pandemic during the first quarter of 2020 and COVID-19 related costs associated with the health and safety of our associates and non-productive labor.

~~Mexico Segment~~

The increase in the income from operations in the Mexico segment for the three months ended September 30, 2020 as compared to the same period in 2019 was primarily due to the net increase in overall wind blade volume, an increase in the average sales price of wind blades noted above, a decrease in the startup and transition costs, foreign currency fluctuations, savings in raw material costs and lower direct labor costs. The fluctuating U.S. dollar relative to the Mexican Peso had a favorable impact of 2.0% on cost of goods sold for the three months ended September 30, 2020 as compared to 2019.

~~The slight decrease in the loss from operations in the Mexico segment for the nine months ended September 30, 2020 as compared to the same period in 2019 was primarily due to the overall~~ increase in wind blade volume, an increase in the average sales price of wind blades ~~noted above, decreased~~produced and a decrease in direct labor costs.

Asia Segment

The decrease in the income from operations in the Asia segment for the three and nine months ended September 30, 2021, as compared to the same periods in 2020, was primarily due to the decrease in the net sales of wind blades, an increase in direct material costs and foreign currency fluctuations. The fluctuating U.S. dollar against the Chinese Renminbi had an unfavorable impact of 4.9% and 5.9% on cost of goods sold for the three and nine months ended September 30, 2021, respectively, as compared to the 2020 periods.

Mexico Segment

The increase in the loss from operations in the Mexico segment for the three and nine months ended September 30, 2021, as compared to the same periods in 2020, was primarily due to an increase in direct material costs and startup and transition costs ~~foreign currency fluctuations as well as from savings in raw material costs. These increases were mostly~~related to the Matamoros and Juarez, Mexico production delays described above, partially offset by an increase in the ~~reduced~~period over period number of wind blades still in the production ~~levels~~process at ~~our Mexico manufacturing facilities due~~the end of the period, an increase in the average sales price of wind blades, and a decrease in warranty costs as compared to the ~~COVID-19 pandemic during the second quarter of~~ 2020 ~~and COVID-19 related costs associated with the health and safety of our associates and non-productive labor.~~periods. The fluctuating U.S. dollar relative to the Mexican Peso had ~~a favorable~~an unfavorable impact of ~~2.1%~~1.5% and 1.2% on cost of goods sold for the three and nine months ended September 30, ~~2020~~2021, respectively, as compared to ~~2019.~~the 2020 periods.

~~EMEAI~~EMEA Segment

The increase in the ~~loss~~income from operations in the ~~EMEAI~~EMEA segment for the three and nine months ended September 30, ~~2020~~2021, as compared to the same ~~period~~periods in ~~2019~~2020, was primarily driven by ~~the decreased~~increased wind blade production at our two Turkey manufacturing facilities ~~increased~~and an increase in the average sales price of wind blades produced. In addition, for the three and nine months ended September 30, 2021, there was a decrease in startup and transition costs ~~at one of our Turkey manufacturing facilities,~~ and ~~increased startup~~an increase in direct material costs ~~at our India manufacturing facility, partially offset by favorable foreign currency fluctuations.~~as compared to the 2020 period. Additionally, for the nine months ended September 30, 2021, there was a decrease in warranty costs as compared to the

2020 period. The fluctuating U.S. dollar relative to the Turkish Lira and Euro had aan favorable impact of ~~3.4%~~2.8% and 0.9% on cost of goods sold for the three and nine months ended September 30, ~~2020~~2021, respectively, as compared to ~~2019.~~the 2020 periods.

India Segment

The ~~increase~~decrease in the loss from operations in the ~~EMEAI~~India segment for the three and nine months ended September 30, ~~2020~~2021, as compared to the same ~~period~~periods in ~~2019~~2020, was ~~primarily~~ driven by ~~increased warranty costs, decreased wind blade~~the commencement of production at our two Turkey manufacturing facilities due to the COVID-19 pandemic during the second quarter of 2020 and COVID-19 related costs associated with the health and safety of our associates and non-productive labor, the increased startup costs at our India manufacturing facility and transition costs atfor one of our ~~Turkey manufacturing facilities, partially offset by favorable foreign currency fluctuations. The fluctuating U.S. dollar relative to~~customers in 2020, and the ~~Turkish Lira and Euro had a favorable impact~~ramp up of ~~3.5% on cost of goods sold for the nine months ended September 30, 2020 as compared to 2019.~~such production in 2021.

Other income (expense)

The following table summarizes our total other income (expense) for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:

Three Months Ended

Nine Months Ended

September 30,

Change

September 30,

Change

2020

2019

$

%

2020

2019

$

%

(in thousands)

(in thousands)

Interest income

$
15

$
43

$
(28
)

-65.1
%

$
55

$
125

$
(70
)

-56.0
%
Interest expense

(3,108
)

(2,130
)

(978
)

-45.9
%

(7,464
)

(6,403
)

(1,061
)

-16.6
%
Realized gain (loss) on
  foreign currency
  remeasurement

(17,127
)

3,719

(20,846
)

NM

(18,095
)

(1,050
)

(17,045
)

NM

Miscellaneous income

1,259

517

742

143.5
%

2,893

2,235

658

29.4
%
Total other income
  (expense)

$
(18,961
)

$
2,149

$
(21,110
)

NM

$
(22,611
)

$
(5,093
)

$
(17,518
)

NM


	Three Months Ended												Nine Months Ended
	September 30,						Change						September 30,						Change
	2021			2020			$			%			2021			2020			$			%
	(in thousands)												(in thousands)
Interest expense, net	$	(2,662	)	$	(3,093	)	$	431			13.9	%	$	(8,057	)	$	(7,409	)	$	(648	)		-8.7	%
Foreign currency income (loss)		3,958			(17,127	)		21,085			123.1	%		(6,273	)		(18,095	)		11,822			65.3	%
Miscellaneous income		262			1,259			(997	)		-79.2	%		1,322			2,893			(1,571	)		-54.3	%
Total other income (expense)	$	1,558		$	(18,961	)	$	20,519			108.2	%	$	(13,008	)	$	(22,611	)	$	9,603			42.5	%

The ~~increase~~decrease in the total other expense ~~in both~~for the three and nine months ended September 30, 2021, as compared to the same periods ofin 2020, was primarily due to ~~increases~~a decrease in ~~realized losses on~~the foreign currency ~~remeasurement~~loss primarily due to net Euro liability exposure against the Turkish Lira in the current year periods as compared to the same periods in ~~2019.~~2020.

Income taxes

The following table summarizes our income taxes for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:


	Three Months Ended									Nine Months Ended											Three Months Ended												Nine Months Ended
	September 30,						Change			September 30,						Change					September 30,						Change						September 30,						Change
	2020			2019			$		%	2020			2019			$		%			2021			2020			$			%			2021			2020			$			%
	(in thousands)									(in thousands)											(in thousands)												(in thousands)
Income tax benefit (provision)	$	32,338		$	(18,838	)	$	51,176	NM	$	(1,946	)	$	(14,713	)	$	12,767		86.8	%	$	(8,248	)	$	32,338		$	(40,586	)		-125.5	%	$	(30,036	)	$	(1,946	)	$	(28,090	)	NM
Effective tax rate		322.0	%		-132.0	%					8.7	%	NM									-36.8	%		-322.0	%								-71.1	%		-8.7	%

~~The decrease in the provision during the three and nine months ended September 30, 2020 was primarily due~~See Note 9, Income Taxes, to ~~the impact of a change in the forecasted annual effective tax rates and the earnings mix by jurisdiction in 2020 as compared to 2019. The forecasted effective tax rate~~our condensed consolidated financial statements for ~~the current year differs from the U.S. statutory~~more details about our income tax rate primarily due to earnings in foreign jurisdictions with income tax rates that exceed the U.S. statutory income tax rate, losses incurred by an entity in a tax-free zone, and the establishment of a full valuation allowance on U.S. deferred items.

~~Net income (loss)~~

~~The following table summarizes our net income (loss)~~taxes for the three and nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020.

Three Months Ended

Nine Months Ended

September 30,

Change

September 30,

Change

2020

2019

$

%

2020

2019

$

%

(in thousands)

(in thousands)

Net income (loss)

$
42,382

$
(4,571
)

$
46,953

NM

$
(24,211
)

$
(14,847
)

$
(9,364
)

-63.1
%

~~The increase in the net income for the three months ended September 30, 2020 as compared to the same period in 2019 was primarily due to the reasons set forth above. In addition, we estimate~~LIQUIDITY AND CAPITAL RESOURCES

Our liquidity and capital resources were adversely affected by certain events that ~~our net income~~occurred during the three months ended September 30, ~~2020 was~~2021. We experienced significant production delays that occurred at the Matamoros, Mexico manufacturing facility that we took over from Nordex in July 2021, as well as significant production delays in one of our Juarez, Mexico manufacturing facilities in connection with the ongoing transition to an innovative new blade for one of our customers. Although we expect that production will be stabilized in both of these manufacturing facilities by the end of the year, we expect that these transitions will continue to have an adverse impact on our liquidity for the remainder of the year. We also expect decreased demand for our wind blades from our customers during the remainder of 2021 and 2022. We believe this decrease in demand is due to the continued global renewable energy regulatory and policy uncertainty and raw material cost increases and constraints. We believe this decreased demand will also adversely ~~impacted by approximately $2 million, net~~impact our profitability and liquidity for the remainder of ~~taxes based upon the forecasted gross margin on the wind blade sets we had forecasted to produce~~2021 and 2022.

We were not in ~~the period under non-cancellable purchase orders associated~~compliance with our ~~long-term contracts but were unable to do so~~Total Net Leverage Ratio financial covenant as ~~a result~~ of the COVID-19 pandemic. In addition, during the period we incurred $4 million, net of taxes, of COVID-19 related costs associated with the health and safety of our associates and non-productive labor. The diluted net income per share was $1.13 for the three months ended September 30, ~~2020, compared to a diluted net loss per share of $0.13 for the three months ended September 30, 2019.~~

~~The increase in the net loss for the nine months ended September 30, 2020 as compared to the same period in 2019 was~~2021, primarily due to the ~~reasons set forth~~Mexico production delays and increased raw material costs and constraints described above. ~~In addition,~~On November 8, 2021 (the Waiver Effective Date), we ~~estimate~~and the lenders that are parties to the Credit Agreement executed a limited waiver pursuant to which the lenders

agreed to temporarily waive our ~~net loss during~~compliance with this financial covenant from the ~~nine months ended September 30, 2020 was adversely impacted by approximately $21~~Waiver Effective Date through December 8, 2021. We also must maintain domestic U.S. cash of at least $20.0 million ~~net~~and global available liquidity of ~~taxes, based upon~~at least $50.0 million as of the ~~forecasted gross margin~~close of business on each Friday commencing as of November 5, 2021 through the ~~wind blade sets~~maturity date of the Credit Agreement. From and after the Waiver Effective Date, we may not allow any of our subsidiaries that are not loan parties to the Credit Agreement to incur any additional indebtedness and we may not make any investment in any of its subsidiaries that are not loan parties to the Credit Agreement in an aggregate amount greater than $5.0 million. We had ~~forecasted~~$68.3 million of domestic U.S cash and $132.9 million of global available liquidity as of October 29, 2021.

Given these near-term liquidity challenges, on November 8, 2021, we entered into the Purchase Agreement pursuant to ~~produce at~~which we agreed to issue and sell to the Purchasers 350,000 shares of our ~~Mexico, China, Iowa, Turkey and India manufacturing facilities~~newly designated Series A Preferred Stock, par value $0.01 per share, for an aggregate purchase price of $350.0 million. We expect the closing of this equity financing transaction to occur in the ~~period under non-cancellable purchase orders associated with our long-term contracts but were unable~~fourth quarter of 2021 and intend to ~~do so as a result~~use the net proceeds from the issuance and sale of the ~~COVID-19 pandemic. The COVID-19 pandemic required these manufacturing facilities~~Series A Preferred Stock to ~~either temporarily suspend production or operate at reduced production levels~~ ~~due primarily to certain applicable government-mandated stay at home orders~~ in response to the COVID-19 pandemic, demands from certain of our labor unions to suspend or reduce production and general safety concerns of our associates. In addition, during the period we incurred $11 million, net of taxes, of COVID-19 related costs associated with the health and safety of our associates and non-productive labor. The diluted net loss per share was $0.68 for the nine months ended September 30, 2020, compared to a diluted net loss per share of $0.42 for the nine months ended September 30, 2019.

~~Liquidity and Capital Resources~~

As a result of the uncertainty relating to: (i) the rapidly evolving nature, magnitude and duration of the COVID-19 pandemic, (ii) the variety of measures implemented by governments around the world to address its effects and (iii) the impact on our manufacturing operations, we are managing our liquidity to ensure our long-term viability until the COVID-19 pandemic abates. During the nine months ended September 30, 2020, we had net borrowings of $72.8 millionrepay all outstanding indebtedness under our Credit ~~Agreement. In addition,~~Agreement and the remainder for general corporate purposes. We also may elect at our option to require Oaktree to purchase an additional $50.0 million of Series A Preferred Stock upon the same terms and conditions as the initial issuance of the Series A Preferred Stock during the ~~nine months ended September 30, 2020, we entered into or amended four unsecured credit agreements with four Turkish~~two-year period following the Closing Date.

See Note 15, Subsequent Events, to our condensed consolidated financial ~~institutions resulting in net borrowings of $31.2 million~~statements for more details on the limited waiver and ~~current availability of $44.0 million.~~the Purchase Agreement.

Our primary needs for liquidity have been, and in the future will continue to be, capital expenditures, new facility startup costs, the impact of transitions, working capital, debt service costs, warranty costs and ~~warranty costs.~~restructuring costs associated with the optimization of our global footprint. Our capital expenditures have been primarily related to machinery and equipment ~~for~~at our new facilities ~~or facility expansions.~~and expansion and improvements at our existing facilities. Historically, we have funded our working capital needs through cash flows from operations, the proceeds received from our credit facilities and from proceeds received from the issuance of stock. We had net ~~borrowings~~proceeds under our financing arrangements of ~~$96.5~~$43.1 million for the nine months ended September 30, ~~2020~~2021 as compared to net ~~repayments~~proceeds under our financing arrangements of ~~$0.2~~$96.5 million in the comparable period of ~~2019.~~2020. As of September 30, ~~2020~~2021 and December 31, ~~2019,~~2020, we had ~~$238.7~~$262.8 million and ~~$142.1~~$217.9 million in outstanding indebtedness, excluding debt issuance costs, respectively. As of September 30, ~~2020,~~2021, we had an aggregate of ~~$88.0~~$103.6 million of remaining capacity and ~~$71.4~~$66.2 million of remaining availability under our various credit facilities. Working capital requirements have increased as a result of our overall growth and the need to fund higher accounts receivable and inventory levels as our business volumes have ~~increased.~~increased, as well as increased raw material costs primarily related to resin, carbon fiber and logistics. Based upon current and anticipated levels of operations, we believe that cash on hand, available credit facilities, the anticipated net proceeds from the preferred equity financing described above, which we believe is probable, and cash ~~flow~~flows from operations will be adequate to fund our working capital and capital expenditure requirements and to make required payments of principal and interest on our indebtedness over the next twelve months.

We anticipate that any new facilities and future facility expansions will be funded through cash flows from operations, the incurrence of other indebtedness and other potential sources of liquidity. At September 30, ~~2020~~2021 and December 31, ~~2019,~~2020, we had unrestricted cash, cash equivalents and short-term investments totaling ~~$149.4~~$119.0 million and ~~$70.3~~$129.9 million, respectively. The September 30, ~~2020~~2021 balance includes ~~$73.4~~$48.5 million of cash located outside of the United States, including ~~$47.2~~$20.7 million in China, ~~$18.8~~$17.9 million in Turkey, ~~$6.2~~$7.3 million in India, ~~$1.0~~$1.9 million in Mexico and ~~$0.2~~$0.7 million in other countries. In February 2020, we entered into an Incremental Facility Agreement with the current lenders to our Credit Agreement and an additional lender, pursuant to which the aggregate principal amount of our revolving credit facility under the Credit Agreement was increased from $150.0 million to $205.0 million.

Our ability to repatriate funds from China ~~to the United States~~ is subject to a number of restrictions imposed by the Chinese government. We repatriate funds through several technology license and corporate/administrative service agreements. We are compensated quarterly based on agreed upon royalty rates for such intellectual property licenses and quarterly fees for those services. Certain of our subsidiaries are limited in their ability to declare dividends without first meeting statutory restrictions of ~~the People’s Republic of~~ China, including retained earnings as determined under Chinese-statutory accounting requirements. Until 50% ($~~26.5~~26.6 million as of September 30, 2021 and December 31, ~~2019)~~2020) of registered capital is contributed to a surplus reserve, our ~~Chinese~~China operations can only pay dividends equal to 90% of after-tax profits (10% must be contributed to the surplus reserve). Once the surplus reserve fund requirement is met, our ~~Chinese~~China operations can pay dividends equal to 100% of after-tax profit assuming other conditions are met. At September 30, 2021 and December 31, ~~2019,~~2020, the amount of the surplus reserve fund was ~~$6.6 million.~~ $9.4 million and $7.0 million, respectively. In July 2021, China paid a dividend of approximately $19.5 million, net of withholding taxes, to our subsidiary in Switzerland.

Financing Facilities

Our total principal amount of debt outstanding as of September 30, 2021 was $262.8 million, including our Credit Agreement, secured and unsecured financing, working capital and term loan agreements and equipment finance leases. See Note 5, Long-Term Debt, Net of Current Maturities, and Note 15, Subsequent Events, to our condensed consolidated financial statements for more details on our debt balances.

Cash Flow Discussion

The following table summarizes our key cash flow activity for the nine months ended September 30, ~~2020~~2021 and ~~2019:~~2020:

	Nine Months Ended
	September 30,									Nine Months Ended
	2020			2019			$ Change			September 30,
	(in thousands)									2021			2020			$ Change
Net cash provided by operating activities	$	33,865		$	62,735		$	(28,870	)
										(in thousands)
Net cash provided by (used in) operating activities										$	(28,241	)	$	33,865		$	(62,106	)
Net cash used in investing activities		(53,428	)		(60,194	)		6,766			(30,138	)		(53,428	)		23,290
Net cash provided by financing activities		102,427			2,358			100,069			48,280			102,427			(54,147	)
Impact of foreign exchange rates on cash, cash equivalents and restricted cash											(939	)		(3,204	)		2,265
Net change in cash, cash equivalents and restricted cash										$	(11,038	)	$	79,660		$	(90,698	)

Operating Cash Flows

Net cash provided by operating activities decreased by ~~$28.9~~$62.1 million for the nine months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019~~2020, primarily as a result of lower operating results and ~~certain changes in our~~unfavorable working ~~capital.~~capital usage.

Investing Cash Flows

Net cash used in investing activities decreased by ~~$6.8~~$23.3 million for the nine months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019 primarily~~2020, as a result of a decrease in capital expenditures.

We anticipate fiscal year ~~2020~~2021 capital expenditures of between ~~$80~~$40 million to ~~$90~~$45 million and we estimate that the cost that we will incur after September 30, ~~2020~~2021 to complete our current projects in process will be approximately ~~$13.0~~$7.0 million. ~~We are deferring non-critical capital expenditures in light of the COVID-19 uncertainty.~~ We have used, and will continue to use, cash flows from operations, the proceeds received from our credit facilities and the proceeds received from the issuance of stock for major projects currently being undertaken, which include new manufacturing facilities in Chennai, India and the continued investment in our existing Tukey, Mexico, China and U.S. ~~facilities as well as in our pilot line in Warren, Rhode Island.~~ facilities.

Financing Cash Flows

Net cash provided by financing activities ~~increased~~decreased by ~~$100.1~~$54.1 million for the nine months ended September 30, ~~2020~~2021, as compared to the same period in ~~2019~~2020, primarily as a result of ~~increased~~decreased net borrowings on our revolving ~~loans and other growth-related debt.~~loans.

OFF-BALANCE SHEET TRANSACTIONS

~~Financing Facilities~~

~~Our total principal amount of debt outstanding as of September 30, 2020 was $238.7 million, including our Credit Agreement, unsecured financing agreements and equipment finance leases. See Note 5,~~ ~~Long-Term Debt, Net of Debt Issuance Costs and Current Maturities, to our condensed consolidated financial statements for a discussion of our debt balances.~~

~~Off-Balance Sheet Transactions~~

We are not presently involved in any off-balance sheet arrangements, including transactions with unconsolidated special-purpose or other entities that would materially affect our financial position, results of operations, liquidity or capital resources, other than our accounts receivable assignment agreements described below. Furthermore, we do not have any relationships with special-purpose or other entities that provide off-balance sheet financing; liquidity, market risk or credit risk support; or engage in leasing or other services that may expose us to liability or risks of loss that are not reflected in the condensed consolidated financial statements and related notes.

Our segments enter into accounts receivable assignment agreements with various financial institutions. Under these agreements, the financial institution buys, on a non-recourse basis, the accounts receivable amounts related to our segment’s customers at an agreed-upon discount rate.

The following table summarizes certain key details of each of the accounts receivable assignment agreements in place as of September 30, ~~2020:~~2021:


Year Of Initial Agreement	Segment(s) Related To	Current ~~Discount~~Annual Interest Rate
2014	Mexico	LIBOR plus 0.75%
~~2018~~2019	~~U.S~~ Asia and Mexico	LIBOR plus ~~1.25%~~1.00%
~~2018~~2019	~~EMEAI~~ Asia	~~EURIBOR plus 0.75%~~
~~2019~~	~~Asia and Mexico~~	~~LIBOR plus 1.00%~~
~~2019~~	~~Asia~~	~~LIBOR plus 1.00%~~
~~2019~~	~~Asia~~	Fixed rate of 3.85%
2020	~~EMEAI~~ EMEA	EURIBOR plus 1.95%
2020	India	LIBOR plus 1.00%
2020	U.S.	LIBOR plus 1.25%
2021	Mexico	LIBOR plus 1.25%

As the receivables are purchased by the financial institutions under the agreements noted above, the receivables ~~were~~are removed from our condensed consolidated balance sheet. During the three months ended September 30, 2021 and 2020, $346.3 million and $343.0 million, respectively, and during the nine months ended September 30, 2021 and 2020, ~~$343.0~~$1,001.2 million and $802.9 million, respectively, of receivables were sold under the accounts receivable assignment agreements described ~~above, respectively.~~above.

~~Critical Accounting Policies and Estimates~~CRITICAL ACCOUNTING POLICIES AND ESTIMATES

There have been no ~~other~~ significant changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K.

~~Recent Accounting Pronouncements~~RECENT ACCOUNTING PRONOUNCEMENTS

See Note 1, ~~Recently Issued Accounting Pronouncements~~Basis of Presentation, under the heading “Accounting Pronouncements” to our condensed consolidated financial statements for a discussion of recent accounting pronouncements.

~~Contractual Obligations~~CONTRACTUAL OBLIGATIONS

During the nine months ended September 30, ~~2020,~~2021, there have been no material changes to the contractual obligations reported in our Annual Report on Form 10-K, other than in the ordinary course of business.

Item 3. ~~Quantitative and Qualitative Disclosures about Market Risk~~QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk in the ordinary course of our business. These market risks are principally limited to changes in foreign currency exchange rates and commodity prices. ~~We currently do not hedge our exposure to these risks.~~

Foreign Currency Risk. We conduct international operations in China, Mexico, Turkey and India. Our results of operations are subject to both currency transaction risk and currency translation risk. We incur currency transaction risk whenever we enter into either a purchase or sale transaction using a currency other than the local currency of the transacting entity. With respect to currency translation risk, our financial condition and results of operations are measured and recorded in the relevant domestic currency and then translated into U.S. dollars for inclusion in our condensed consolidated financial statements. In recent years, exchange rates between these foreign currencies and the U.S. dollar have fluctuated significantly and may do so in the future. A hypothetical change of 10% in the exchange rates for the countries above would have resulted in a change to income from operations of approximately ~~$33.6~~$21.5 million for the nine months ended September 30, ~~2020.~~2021.

Commodity Price Risk. We are subject to commodity price risk under agreements for the supply of our raw materials. We have not hedged our commodity price exposure. We generally lock in pricing for most of our key raw materials for 12 months which protects us from price increases within that ~~period.~~period, which we believe helps to mitigate the impact of raw material price increases. As many of our raw material supply agreements have meet or release clauses, if raw materials prices ~~go down,~~decrease, we are able to benefit from the reductions in price. ~~We believe that this adequately protects us from increases in raw material prices and also enables us to take full advantage of decreases.~~

Resin and resin systems are the primary commodities for which we do not have fixed pricing. Approximately ~~40%~~55% of the resin and resin systems we use are purchased under contracts either controlled or borne by ~~one~~two of our customers and therefore they receive/bear 100% of any ~~increase~~decrease or ~~decrease~~increase in resin costs further limiting our exposure to price fluctuations. We

Prior to taking into account any contractual obligations of our customers to share with us the cost savings or increases resulting from a change in the current forecasted price of resin and resin systems, we believe that a 10% change in the current forecasted price of resin and resin systems for the customers in which we are exposed to fluctuating prices would have had an impact to income from

operations of approximately ~~$7.7~~$12.4 million for the ~~nine months ended September 30, 2020. Furthermore, this amount does not include the portion of any increase or decrease that would be shared with~~full year 2021. With respect to our other customer supply agreements, our customers ~~under our long-term supply agreements, which is generally~~typically receive/bear 70%.

~~In late 2019, worldwide demand for balsa wood increased as~~ of the cost savings or increases resulting from a result of shortages of other types of core materials. In addition, our supply chain for balsa wood, which is primarily sourced from Ecuador, has been further stressed due to the COVID-19 pandemic. As a result of this increased demand and supply chain disruption, we currently do not have fixed pricing for a portion of our contracts and purchases orders for balsa wood for the remainder of 2020. We believe that a 10% change in the price of ~~balsa wood would have had an impact to income from operations of approximately $6.1 million for the nine months ended September 30, 2020.~~ resin and resin systems.

Interest Rate Risk. As of September 30, 2020, our EMEAI segment has one general credit agreement, as amended, with a Turkish financial institution which is tied to EURIBOR. This agreement had collateralized financing of capital expenditures and unsecured financing outstanding as of September 30, 2020 totaling $15.8 million. In addition, as of September 30, 2020,2021, our Credit Agreement includes interest on the unhedged principal amount of ~~$110.2~~$106.2 million which is tied to ~~LIBOR.~~the London Interbank Offered Rate (LIBOR), our India segment has two credit agreements outstanding which are tied to LIBOR, and our EMEA segment has one general credit agreement outstanding which is tied to the Euro Interbank Offered Rate (EURIBOR). For a discussion of the interest rate swap arrangement we entered into related to our Credit Agreement, see Note 13, Financial Instruments, to the notes to the consolidated financial statements within our 2020 Annual Report on Form 10-K. The ~~EMEAI financings~~India credit agreements had secured and unsecured working capital financing of $10.3 million and unsecured term loan financing of $8.1 million outstanding as of September 30, 2021. The two EMEA credit agreements had unsecured financing of $5.7 million and financing of capital expenditures of $1.0 million outstanding as of September 30, 2021. Our Credit Agreement, the two India credit agreements, and the ~~Credit Agreement noted above~~one EMEA general credit agreement are the only variable rate debt agreements that we had outstanding as of September 30, ~~2020~~2021 as all remaining ~~working capital loans, accounts receivable financing,~~secured and unsecured financing and ~~capital~~finance lease obligations are fixed rate instruments and are not subject to fluctuations in interest rates. Due to the relatively low LIBOR and EURIBOR rates in effect as of September 30, ~~2020,~~2021, a 10% change in the LIBOR or EURIBOR rate would not have had a material impact on our future earnings, fair values or cash flows.

Item 4. ~~Controls and Procedures~~CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As required by Rule 13a-15(b) promulgated under the Exchange Act, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the design and operating effectiveness as of September 30, ~~2020~~2021 of our disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, ~~2020.~~2021.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended September 30, ~~2020~~2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART ~~II—~~II. OTHER INFORMATION

Item 1. ~~Legal Proceedings~~LEGAL PROCEEDINGS

See Note 12, Commitments and Contingencies, under the heading “Legal Proceedings” to our condensed consolidated financial statements for a discussion of legal proceedings and other related matters.

Item 1A. RISK FACTORS~~Risk Factors~~

Except as noted below, there have been no material changes to the Risk Factors (Part I, Item 1A) in our Annual Report on Form 10-K, which could materially affect our business, financial condition, and/or future results.

The pending Series A Preferred Stock financing may not be completed, which could adversely affect our business, results of operations and/or financial condition or the price of our shares of Common Stock.

On November 8, 2021, we entered into a Series A Preferred Stock Purchase Agreement (the Purchase Agreement) with Oaktree Power Opportunities Fund V (Delaware) Holdings, L.P., OPPS TPIC Holdings, LLC, and Oaktree Phoenix Investment Fund L.P. (collectively, the Purchasers), pursuant to which we have agreed to issue and sell to the Purchasers an aggregate of 350,000 shares of our newly designated Series A Preferred Stock, par value $0.01 per share (the Series A Preferred Stock), for an aggregate purchase price of $350.0 million. On the closing date for the sale of the Series A Preferred Stock, we will also issue the Purchasers a warrant to purchase an aggregate of 4,666,667 shares of our Common Stock, at an exercise price of $0.01 per share. The transaction is expected to close in the fourth quarter of 2021, subject to the conditions set forth in the Purchase Agreement. We cannot assure that all closing conditions will be satisfied or waived. The Purchase Agreement will expire if the closing has not occurred by the 60th day following the date of the Purchase Agreement. If the transaction is not completed, we will be subject to a number of risks, including: we must pay costs related to the transaction, including legal and financial advisory fees, whether the transaction is completed or not; the trading price of our shares of Common Stock may decline if the transaction is not completed, to the extent that the market price reflects a market assumption that the transaction will be completed; we may be required to seek alternative sources of liquidity, as to the availability or terms of which we cannot provide assurance, and we could be subject to litigation related to the failure to complete the transaction or other factors, all of which may adversely affect our business, results of operations and/or financial results and the price of our shares of Common Stock.

Our business, operations and financial condition ~~for~~during the nine months ended September 30, ~~2020 have been~~2021 were not materially adversely affected by the COVID-19 pandemic ~~and~~however we cannot estimate the duration ~~and magnitude~~ of the COVID-19 pandemic onand our business ~~operations and financial condition at this time.~~may be adversely affected in the future if the COVID-19 pandemic persists.

The COVID-19 pandemic ~~has~~did not materially adversely ~~affected~~affect our ~~business and~~manufacturing operations ~~for~~during the nine months ended September 30, ~~2020. During~~2021. However, our manufacturing facility in Yangzhou, China was shut down for approximately three weeks during the ~~first quarter~~three months ended September 30, 2021 due to an outbreak of ~~2020,~~positive COVID-19 cases in Yangzhou City, which had an adverse impact on our ~~China manufacturing facilities were adversely impacted by~~results of operations for the COVID-19 pandemic in the form of reduced production levels and COVID-19 related costs associated with the health and safety of our associates and non-productive labor. During the second quarter of 2020,three months ended September 30, 2021. Although all of our manufacturing facilities ~~with the exception of our China manufacturing facilities and our Rhode Island manufacturing facility were required to temporarily suspend production or operate at reduced production levels~~ ~~due primarily to certain applicable government-mandated stay at home orders~~ in response to the COVID-19 pandemic, demands from certain of our labor unions to suspend or reduce production and general safety concerns of our associates. By the end of the second quarter of 2020, most of our manufacturing facilities had returned tocurrently are operating at or near normal production ~~levels. However, several of our manufacturing facilities are operating in regions with high~~ levels, ~~of reported COVID-19 positive cases. As such,~~ we may be required to reinstate temporary production suspensions or volume reductions at ~~these manufacturing facilities or at~~ our ~~other~~ manufacturing facilities to the extent there ~~is a resurgence~~are new resurgences of COVID-19 cases in the regions where we operate or there is an outbreak of positive COVID-19 cases in any of our manufacturing facilities. ~~In addition, although we currently have not experienced any significant disruptions in~~However, our global supply chain ~~due to~~has been adversely affected by the COVID-19 pandemic in 2021 and our global supply chain may ~~in the future~~continue to be adversely affected if the COVID-19 pandemic persists.

Item 2. ~~Unregistered Sales of Equity Securities and Use of Proceeds~~UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

Not applicable.

Use of Proceeds

Not applicable.

Item 3. ~~Defaults Upon Senior Securities~~DEFAULTS UPON SENIOR SECURITIES

Not applicable.

Item 4. ~~Mine Safety Disclosures~~MINE SAFETY DISCLOSURES

Not applicable.

Item 5. ~~Other Information~~OTHER INFORMATION

None.

Item 6. EXHIBITS~~Exhibits~~


Exhibit Number		Exhibit Description

~~31.1~~ 31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

~~31.2~~ 31.2*		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

~~101.SCH~~101.INS*		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document ~~(filed herewith)~~
101.CAL*
~~101.CAL~~		Inline XBRL Taxonomy Extension Calculation Linkbase Document ~~(filed herewith)~~
101.DEF*
~~101.DEF~~		Inline XBRL Taxonomy Extension Definition Linkbase Document ~~(filed herewith)~~
101.LAB*
~~101.LAB~~		Inline XBRL Taxonomy Extension Label Linkbase Document ~~(filed herewith)~~
101.PRE*
~~101.PRE~~		Inline XBRL Taxonomy Extension Presentation Linkbase Document ~~(filed herewith)~~
104*
~~104~~		Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) ~~(filed herewith)~~

* Filed herewith.

** The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.

SIGNATURES

The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.

~~SIGNATURES~~

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	TPI COMPOSITES, INC.


Date: November ~~5, 2020~~ 9, 2021	By:	/s/ Adan Gossar
		Adan Gossar
		Chief Accounting Officer
		(Principal Accounting Officer)

4143

	Nine Months Ended September 30, 2019

							Accumulated
	Common				Paid-in		other comprehensive			Accumulated			Treasury stock,			Total stockholders'
	Shares		Amount		capital		loss			deficit			at cost			equity
	(in thousands)
Balance at December 31, 2018		34,745	$	347	$	311,771	$	(14,392	)	$	(74,981	)	$	(1,788	)	$	220,957
Net loss		—		—		—		—			(12,104	)		—			(12,104	)
Share-based compensation expense		—		—		821		—			—			—			821
Issuances under share-based compensation plan		355		4		4,635		—			—			—			4,639
Common stock repurchased for treasury		—		—		—		—			—			(559	)		(559	)
Other comprehensive loss		—		—		—		(477	)		—			—			(477	)
Balance at March 31, 2019		35,100		351		317,227		(14,869	)		(87,085	)		(2,347	)		213,277
Net income		—		—		—		—			1,828			—			1,828
Share-based compensation expense		—		—		2,057		—			—			—			2,057
Issuances under share-based compensation plan		41		—		144		—			—			—			144
Other comprehensive loss		—		—		—		(5,274	)		—			—			(5,274	)
Balance at June 30, 2019		35,141		351		319,428		(20,143	)		(85,257	)		(2,347	)		212,032
Net loss		—		—		—		—			(4,571	)		—			(4,571	)
Share-based compensation expense		—		—		1,905		—			—			—			1,905
Issuances under share-based compensation plan		158		2		7		—			—			—			9
Common stock repurchased for treasury		—		—		—		—			—			(1,561	)		(1,561	)
Other comprehensive loss		—		—		—		(1,649	)		—			—			(1,649	)
Balance at September 30, 2019		35,299	$	353	$	321,340	$	(21,792	)	$	(89,828	)	$	(3,908	)	$	206,165

	Three Months Ended September 30, 2019
	U.S.		Asia		Mexico		EMEAI		Total
	(in thousands)
Wind blade sales	$	25,857	$	98,406	$	111,855	$	116,084	$	352,202
Precision molding and assembly systems sales		1,479		8,915		4,655		—		15,049
Transportation sales		8,061		—		—		—		8,061
Other sales		5,246		793		1,180		1,305		8,524
Total net sales	$	40,643	$	108,114	$	117,690	$	117,389	$	383,836

	Condensed	Three Months Ended				Nine Months Ended
Comprehensive Income	Consolidated Statement	September 30,				September 30,
(Loss) Component	of Operations Line Item	2020		2019		2020		2019
		(in thousands)
Foreign exchange forward contracts	Cost of sales	$	1,546	$	—	$	4,062	$	—